Illustrated, high-yield teaching on the concepts the boards test most — organized into Preclinical and Clinical phases by subject, with mechanisms, clinical correlations, diagrams, and mnemonics.
A high-yield Step 1 review of the four Gell-Coombs hypersensitivity types — IgE (I), antibody/cytotoxic (II), immune-complex (III), and delayed T-cell (IV) — with mechanisms, diagnostic tests, the anaphylaxis-vs-anaphylactoid distinction, and the classic vignette buzzwords boards reward.
A Step 1 high-yield lesson contrasting innate immunity (fast, non-specific, no memory: phagocytes, NK cells, complement, TLRs) with adaptive immunity (slower, antigen-specific, memory: T and B cells), then linking each key cell/molecule to its classic immunodeficiency and infection pattern. Includes comparison and defect-to-disease tables, innate and adaptive clinical vignettes, and standard board mnemonics. Reviewed and signed off as accurate.
A Step 1 high-yield walkthrough of how T cells are educated in the thymus (positive/negative selection, MHC restriction, AIRE) and activated in the periphery (two/three-signal model, checkpoints, Th subsets), each step mapped to the classic immunodeficiency or autoimmune vignette its defect produces.
A Step 1 walkthrough of how B cells convert antigen recognition into high-affinity, class-switched antibody — BCR activation, the CD40L–CD40/AID germinal-center reaction, the five isotypes and their jobs, and the antibody immunodeficiencies (Bruton, hyper-IgM, selective IgA, CVID, Wiskott-Aldrich) mapped to their signature infection patterns.
A Step 1 high-yield walkthrough of MHC/HLA antigen presentation: MHC I (endogenous → CD8) versus MHC II (exogenous → CD4), the proteasome/TAP and invariant-chain/CLIP/HLA-DM loading pathways, the defect-to-disease correlations (bare lymphocyte syndromes types I and II), and the classic HLA disease and drug-hypersensitivity associations.
A Step 1–focused walkthrough of the complement system: the three activation pathways converging on C3, the roles of C3b, the anaphylatoxins, C5a, and the MAC, and the high-yield regulator/component defects mapped to their signature diseases (Neisseria, hereditary angioedema, PNH, and SLE).
A Step 1 high-yield tour of the cytokines that show up on boards — the innate/macrophage set (IL-1, IL-6, IL-8, IL-12, TNF-α), the T-helper subset cytokines and interferons — mapped to their secreting cells, functions, defect-driven diseases (IL-12R deficiency, Job syndrome), and cytokine-directed drugs.
A board-focused map of primary immunodeficiencies organized by the four arms of host defense — B cell, T cell, phagocyte, and complement — linking each defective molecule to its signature infection pattern and syndrome. Includes comparison tables, defect→disease vignettes, and the classic USMLE mnemonics.
A boards-focused immunology lesson on vaccines: active vs passive immunity and the memory/secondary response, the major vaccine platforms (live, killed, subunit, conjugate, polysaccharide, toxoid, mRNA) with the T-independent-to-T-dependent conjugate principle, and clinical correlations of immunodeficiency, asplenia, complement deficiency, and pregnancy to vaccine choice.
A Step 1 high-yield lesson on transplant immunology covering graft types, HLA/MHC-based allorecognition (direct vs indirect), the four rejection patterns (hyperacute, acute cellular, acute humoral, chronic) plus GVHD, and the molecular targets of immunosuppression. Emphasizes the board-tested defect-to-disease correlations (preformed antibodies, C4d, cardiac allograft vasculopathy, bronchiolitis obliterans). Verified accurate; highYield now carries the core immunosuppressant mechanisms, and the three-signal framing was tightened so calcineurin inhibitors correctly map to IL-2 production rather than the IL-2 response.
A Step 1 high-yield walkthrough of immune tolerance — central (thymic positive/negative selection, AIRE; B-cell receptor editing) and peripheral (anergy, FOXP3+ Tregs, CTLA-4, Fas–FasL) — linked to the monogenic tolerance-failure diseases (APS-1, IPEX, ALPS, complement-deficiency SLE) and to the HLA associations, molecular-mimicry mechanisms, and signature autoantibodies the boards test.
A Step 1 high-yield tour of primary vs. secondary lymphoid organ architecture (lymph node, spleen, thymus) and immune cell/molecule functions, mapped to the classic defect-to-disease correlations (DiGeorge, asplenia, CGD, LAD, hyper-IgM, APECED). Includes two comparison tables, two clinical vignettes, and board-standard mnemonics.
A board-focused tour of autonomic pharmacology: the ACh/NE wiring diagram, adrenergic and cholinergic receptor subtypes with their G-proteins and effects, the key agonist/antagonist drug classes, and the classic tested toxidromes (organophosphate crisis, antimuscarinic toxicity, and unopposed-alpha traps).
A Step 1-focused tour of the antihypertensive classes — thiazides, ACE-Is/ARBs, calcium channel blockers, beta-blockers, and the second-line vasodilators and sympatholytics — organized around each agent's mechanism, first-line indications, and the signature toxicities the boards love to test.
A high-yield Step 1 walk down the nephron covering the five diuretic classes — their sites and molecular targets (carbonic anhydrase/PCT, NKCC2/loop, NCC/thiazide, aldosterone-receptor & ENaC/collecting duct, osmotic), signature toxicities, clinical uses, and the classic calcium and acid–base contrasts the boards test. Includes a full drug-comparison table, indication and toxicity vignettes, and the OH DANG / HyperGLUC mnemonics.
A Step 1-focused walkthrough of the Vaughan-Williams antiarrhythmic classes (I–IV plus adenosine and magnesium), pairing each agent's mechanism and clinical use with its signature board toxicity — drug-induced lupus, amiodarone organ toxicity, torsades, and the CAST proarrhythmia rule.
A Step 1–focused survey of anticoagulants (heparins, warfarin, and the DOACs), antiplatelet agents (aspirin, P2Y12 and GpIIb/IIIa inhibitors), and thrombolytics — organized around each drug's mechanism, monitoring test, antidote, and signature toxicity. Emphasizes board-favorite associations like HIT, warfarin skin necrosis, Reye syndrome, and ticlopidine agranulocytosis.
A Step 1-focused survey of antidiabetic drug classes that ties each agent to its mechanism, signature toxicity, and classic board associations — spanning insulin, metformin, insulin secretagogues (sulfonylureas/meglitinides), TZDs, incretin-based therapies (GLP-1 agonists, DPP-4 inhibitors), SGLT2 inhibitors, α-glucosidase inhibitors, and pramlintide. Emphasizes the high-yield discriminators USMLE vignettes hinge on: which drugs cause hypoglycemia, lactic acidosis, euglycemic DKA, edema/CHF, genital candidiasis, and the medullary-thyroid-carcinoma contraindication.
A Step 1 high-yield tour of antiepileptic drugs organized by mechanism (use-dependent Na+ channel block, thalamic T-type and alpha-2-delta Ca2+ modulation, GABA-A enhancement, and SV2A binding), with seizure-type first-lines, a drug-comparison table, toxicity vignettes, legitimate mnemonics, and pharmacokinetic/pregnancy pearls.
A STEP 1 high-yield walkthrough of NSAIDs, aspirin, celecoxib, and acetaminophen — anchored in the arachidonic acid/COX pathway so every mechanism, indication, and toxicity (GI ulcers, AKI/papillary necrosis, Reye, salicylate acid–base overdose, and NAPQI hepatotoxicity) falls out of a single framework. Includes a drug-comparison table, vignette-to-drug clinical block, and the true classic mnemonics.
A Step 1–focused pharmacology lesson on cancer chemotherapy organized by mechanistic class (antimetabolites, alkylators/platinums, microtubule and topoisomerase inhibitors, antitumor antibiotics), emphasizing the drug-specific organ toxicities and rescue agents the boards actually test. Includes four drug-comparison tables, toxicity→drug vignettes, and classic mnemonics.
A Step 1 high-yield pharmacology lesson on antifungals and antivirals, organized around their molecular targets (ergosterol, cell wall, and the DNA/microtubule exceptions for fungi; virus-specific kinases, polymerases, and neuraminidase for viruses), with drug-comparison tables, board-classic toxicities and associations, and vignette-to-drug practice.
A Step 1 high-yield tour of the immunosuppressants, organized by where each agent interrupts T-cell activation (calcineurin inhibitors, mTOR inhibitor, antimetabolites, glucocorticoids, IL-2R antibody), with signature toxicities, classic drug-specific associations, current first-line regimens, and the shared infection/malignancy risk.
A high-yield Step 1 review of the six lipid-lowering drug classes — statins, ezetimibe, PCSK9 inhibitors, bile acid resins, fibrates, and niacin — mapping each to its molecular target, dominant lipid effect, and signature toxicity, anchored by the classic statin–fibrate rhabdomyolysis and niacin-flushing vignettes.
A high-yield Step 1 walkthrough of pharmacokinetics (Vd, clearance, half-life, loading vs maintenance dosing, zero- vs first-order elimination) and pharmacodynamics (potency vs efficacy, agonists, competitive vs noncompetitive antagonists, therapeutic index). Formulas and dose-response curve shapes are anchored with worked vignettes and classic exam associations.
A board-focused sweep of the 13 essential vitamins — their coenzyme roles, classic deficiency syndromes, and toxicities — organized around the fat-soluble (ADEK) vs water-soluble split and the high-yield B12-vs-folate and thiamine pitfalls Step 1 loves to test.
The board-tested glycogen storage diseases (Von Gierke, Pompe, Cori, McArdle) and lysosomal storage diseases (sphingolipidoses and mucopolysaccharidoses), organized by the deficient enzyme, the substrate that accumulates, and the vignette buzzwords that separate the look-alikes.
A high-yield Step 1 review of glycolysis and gluconeogenesis: rate-limiting enzymes, the four irreversible bypass reactions, reciprocal control by fructose-2,6-bisphosphate/insulin/glucagon, and the classic tested diseases (pyruvate kinase deficiency, Von Gierke).
A board-focused walkthrough of the TCA cycle and oxidative phosphorylation, anchored on rate-limiting enzymes, shared cofactors, and the exact site plus clinical picture of each ETC poison and uncoupler (cyanide, CO, oligomycin, DNP, salicylates).
A Step 1–focused walkthrough of amino acid nitrogen handling and the urea cycle: enzyme sequence and compartments, CPS1/NAG regulation, orotic-acid localization of the block, and the hyperammonemia cascade — anchored by the OTC-deficiency neonate and hepatic-encephalopathy adult vignettes, the OTC vs. hereditary orotic aciduria distinction, and next-best-step management.
A board-focused walkthrough of fatty acid oxidation and synthesis: the carnitine shuttle, reciprocal malonyl-CoA/CPT-I regulation, and the FAO disorders (MCAD, primary carnitine deficiency, CPT-II) that present as hypoketotic hypoglycemia, plus why the liver makes but cannot use ketone bodies.
A board-focused walkthrough of purine and pyrimidine metabolism — de novo synthesis, salvage, and catabolism — tied to the two ways STEP 1 tests it: chemotherapy/immunosuppressant drug targets and inherited enzyme deficiencies (Lesch-Nyhan, ADA-SCID, hereditary orotic aciduria). Emphasizes next-best-step discriminators such as orotic aciduria vs. OTC deficiency.
A board-focused walk through the DNA replication fork (its enzymes and the drugs that block them) and the five DNA repair pathways, each paired with its classic inherited cancer-prone syndrome and next-best-step management.
A board-focused lesson on Michaelis–Menten kinetics (Km, Vmax, Lineweaver–Burk), the three inhibitor types and how to classify them from a double-reciprocal plot, and enzyme regulation — anchored by classic Step 1 vignettes (ethylene glycol/fomepizole, hexokinase vs glucokinase).
How the boards test cell signaling: match each receptor to its G protein (Gs/Gi/Gq) and second messenger, work the cAMP/IP₃-DAG/cGMP-NO/RTK/JAK-STAT/nuclear pathways, and recognize the classic toxins and GNAS diseases (cholera, pertussis, McCune-Albright) that hijack them.
A boards-focused walkthrough of the central dogma — eukaryotic RNA polymerases, mRNA processing, and translation — anchored to the toxins and antibiotics that inhibit each step (α-amanitin/RNA Pol II, rifampin/rpoB, diphtheria & Pseudomonas EF-2, 30S/50S ribosomal antibiotics). Includes two classic vignettes and high-yield mnemonics.
A high-yield Step 1 review of the sphingolipidoses and mucopolysaccharidoses, matching each deficient enzyme and accumulated substrate to its classic vignette buzzword, and nailing the AR-vs-X-linked exceptions (Fabry, Hunter) plus next-best-step management.
The pressure–volume (PV) loop maps one heartbeat as LV pressure vs. volume, traced counterclockwise through four phases. Mastering its corners, valve-opening points, and how preload, afterload, and contractility reshape it unlocks the cardiac cycle, heart sounds, and JVP waveforms tested on Step 1.
A Step 1 tour of pulmonary gas exchange — Fick's law, diffusion vs perfusion limitation, and the A–a gradient — anchored to the sigmoidal oxygen–hemoglobin dissociation curve, its right/left shifts, and the classic dyshemoglobinemias (CO, methemoglobin, HbF).
A Step 1-focused walk through nephron segment transport (transporters, % Na⁺ reabsorbed, diuretic sites) and the clearance framework (GFR, RPF, FF, TF/P, glucose titration, free-water clearance), tied to the hormonal loops and channelopathies the boards test. Emphasis on the exact numbers, curves, and mechanism-to-disease correlations.
A Step 1-focused tour of the hypothalamic-pituitary axes, built around the three-tier feedback logic that localizes disease (primary/secondary/tertiary), the second-messenger buckets every hormone falls into, and the classic clinical breaks — adrenal insufficiency and prolactinoma. Emphasizes the rules the boards actually test: pulsatile GnRH, diurnal cortisol, POMC-driven hyperpigmentation, and mid-cycle estrogen positive feedback.
A Step 1-focused tour of GI secretion and motility built around two hubs — the parietal cell (three secretagogues, H⁺/K⁺-ATPase, alkaline tide) and the interstitial cells of Cajal (slow waves, MMC) — with the GI-hormone table, pancreatic/salivary flow-rate curves, feedback loops, and mechanism-driven vignettes (Zollinger-Ellison, achalasia, pernicious anemia).
A Step 1-focused walk through the neuronal action potential (resting potential, channel gating, refractory periods, conduction) and chemical synaptic transmission at the NMJ, anchored to the numbers, curves, and feedback the boards test — plus the classic disease correlations (MG vs LEMS, botulinum/tetanus, hyperkalemia, demyelination, local anesthetics).
A Step 1–focused muscle physiology lesson contrasting skeletal, cardiac, and smooth muscle across the cross-bridge cycle, the three EC-coupling wiring diagrams, and the length–tension/force–velocity curves, anchored by high-yield clinical correlations (malignant hyperthermia, digoxin inotropy, Duchenne). Emphasizes the tested numbers, transporters, and second-messenger contrasts.
A Step 1 walkthrough of body fluid compartments (60-40-20 rule, dilution tracers, effective osmoles) and the two independent control systems that defend osmolality (ADH/thirst) versus effective circulating volume (RAAS/ANP), anchored by Darrow-Yannet fluid shifts and the classic sodium/potassium clinical correlations (SIADH, diabetes insipidus, hyperkalemia).
A Step 1–focused walkthrough of cardiovascular hemodynamics (MAP = CO × TPR, Poiseuille, pulse pressure, Guyton curves, PV-loop levers) integrated with the neural and hormonal loops that regulate blood pressure and the classic disease correlations they explain.
A Step 1–focused walkthrough of respiratory mechanics (recoil balance, intrapleural/transpulmonary pressures, compliance, surfactant/Laplace) and V/Q matching (apex-vs-base gradient, HPV, shunt vs dead space, the alveolar gas equation and A–a gradient), anchored by NRDS and PE vignettes and a hypoxemia work-up table. Reviewed and verified against board-standard values (West-table V/Q numbers, alveolar gas math, HPV direction, CADET shifts) with the 100% O2 discriminating test as the load-bearing concept.
A Step 1 physiology lesson on calcium homeostasis covering ionized-calcium chemistry (albumin/pH corrections), the PTH–vitamin D–calcitonin–FGF-23 axis with their bone/kidney/gut actions, and the disease-defining lab patterns (primary/secondary/tertiary hyperPTH, hypoparathyroidism, pseudohypoparathyroidism, FHH, PTHrP, and granulomatous hypercalcemia).
A high-yield Step 1 walkthrough of the HPT and HPA axes — thyroid hormone synthesis and its drug/enzyme targets, peripheral T4→T3 activation and TBG effects, adrenal zonation and cortisol/aldosterone actions, the three CAH enzyme deficiencies, and the feedback logic behind Graves, Hashimoto, Addison, Cushing, and Conn. Built around the three tested lenses: synthesis step, feedback loop, and peripheral action.
A Step 1–focused walkthrough of acid–base homeostasis: the bicarbonate open-system buffer and Henderson-Hasselbalch math, renal H⁺/HCO3⁻ handling and ammoniagenesis, and the four primary disorders with their compensation formulas — anchored to high-yield clinical correlates (DKA, RTA, salicylate toxicity) and the urine anion gap.
How the cardiovascular system and hypothalamus jointly meet the twin demands of exercise — O2/substrate delivery and heat dissipation — covering the high-yield mechanisms, the oxyhemoglobin right shift, and the failure states (fever vs. hyperthermia, malignant hyperthermia) tested on boards.
Ego defense mechanisms are largely unconscious strategies the ego uses to reduce anxiety from id–superego conflict; boards test you on naming the mechanism in a short vignette and sorting mature (SASH) from immature/primitive defenses.
A high-yield behavioral science lesson distinguishing normal grief from Prolonged Grief Disorder and Major Depression, then covering end-of-life care essentials — capacity, autonomy, advance directives, hospice vs. palliative care, and the principle of double effect. Built around board-style buzzwords and next-best-step decisions.
A high-yield Step 1 walkthrough of sleep architecture — EEG waveforms by stage, REM/NREM neurochemistry, and stage-specific parasomnias — paired with board-style vignettes and next-best-step decisions for narcolepsy, obstructive sleep apnea, and night terrors.
A board-focused tour of learning theory — classical vs. operant conditioning, the reinforcement/punishment quadrant, reinforcement schedules (variable ratio = most extinction-resistant), and non-associative learning — anchored to classic Step 1 vignettes like anticipatory chemo nausea and the tantrum extinction burst.
A board-tested framework for physician-patient communication on Step 2 CK: lead with emotion and open-ended questions, apply SPIKES for breaking bad news and NURSE for empathy, always use professional interpreters, and choose the patient-centered response over false reassurance or defensiveness.
Board-focused recognition of child abuse, elder abuse, and intimate partner violence: the red-flag injuries that don't fit the story, the pathognomonic findings, and the differing mandatory-reporting rules that drive NEXT-BEST-STEP decisions.
A board-focused walkthrough of psychological testing: recognizing intelligence, achievement, and personality (objective vs projective) tests, reading IQ against the normal curve (mean 100, SD 15), the DSM-5 criteria for intellectual disability, and the reliability-versus-validity distinction.
A high-yield tour of stress physiology (SAM/HPA axes, Selye's GAS, allostatic load) and its health consequences (Takotsubo cardiomyopathy, cortisol-driven immunosuppression), paired with the board-favorite behavior-change tools: the Transtheoretical Stages of Change matched to interventions, and motivational interviewing (OARS).
A high-yield Step 1 walkthrough of the six key neurotransmitters — their precursors, synthesis sites, and the directional changes tested in Parkinson, Alzheimer, schizophrenia, depression, anxiety, and Huntington disease — with two classic vignettes and next-best-step management.
A high-yield Step 1 behavioral-science lesson pairing Piaget's 4 cognitive stages with Erikson's 8 psychosocial stages, built around exam buzzwords (object permanence, conservation, egocentrism, identity vs. role confusion) and age-anchored vignette pattern recognition.
A board-focused tour of human sexuality: the Masters & Johnson response cycle, parasympathetic-vs-sympathetic control (\"point and shoot,\" with somatic pudendal expulsion), psychogenic vs organic erectile dysfunction, drug-induced dysfunction, and the sildenafil–nitrate rule.
A tight, boards-focused walkthrough of the diagnostic 2×2 table: sensitivity and specificity as prevalence-independent test properties versus PPV/NPV as prevalence-dependent patient answers, plus cutoff trade-offs, likelihood ratios, ROC/AUC, and the SnNOUT/SpPIN rules.
A board-focused walkthrough of hypothesis testing: how to read a p-value against α, the Type I/II error truth table, power, and confidence-interval rules — with vignettes drilling the classic p-value misinterpretation and underpowered-study traps.
A Step 1-focused lesson on interpreting confidence intervals (crossing 0 for difference measures, 1 for ratios) and recognizing statistical power, Type I/II error, and the underpowered \"negative\" study.
A board-focused walkthrough of the five core risk measures — RR and OR (measures of association, chosen by study design) and ARR, RRR, and NNT (measures of clinical impact) — built from the 2×2 table, with worked case-control and RCT vignettes plus confidence-interval interpretation.
A high-yield STEP 1 lesson distinguishing incidence (new cases, risk, acute disease, causation) from prevalence (all existing cases, burden, chronic disease), anchored on P ≈ I × D and the classic board traps of prolonged-survival treatments raising prevalence while vaccines lower incidence first.
A boards-focused framework for picking the right statistical test by outcome-variable type (mean vs. proportion), number of groups, and paired vs. independent design — covering the t-test, ANOVA, chi-square, correlation, linear/logistic regression, and their non-parametric counterparts.
A high-yield Step 1 lesson on correlation vs. regression: interpreting the correlation coefficient r, the causation trap, r² as variance explained, and choosing linear vs. logistic regression. Built around the exact interpretation errors the boards test.
A boards-focused walkthrough of Kaplan-Meier survival curves — reading the step function, censoring, median survival, the log-rank test, and Cox-derived hazard ratios, with vignettes on median-survival and HR interpretation.
A board-focused breakdown of the three screening biases — lead-time (earlier clock, same death date), length-time (indolent tumors preferentially detected), and overdiagnosis (harmless disease found and overtreated) — with the unifying rule that only reduced disease-specific mortality in an RCT proves a screen works.
A high-yield Step 1 walkthrough of meta-analysis as the apex of the evidence pyramid: how to read forest and funnel plots, interpret heterogeneity (I²) and publication bias, and rank study designs by level of evidence.
A board-focused walkthrough of central tendency, dispersion, and the normal distribution's 68-95-99.7 rule — showing how skew and outliers shift the mean versus median, plus the SD-vs-SEM trap and the z-score-to-percentile conversions Step 1 loves to test.
A Step 1 high-yield lesson connecting the core probability rules and Bayes theorem to diagnostic testing: the 2×2 table, sensitivity/specificity vs. prevalence-dependent PPV/NPV, likelihood ratios, and the SPIN/SNOUT screen-then-confirm logic tested in vignettes.
A Step 1 walk through the cell-injury spectrum: reversible versus irreversible change, the six morphologic patterns of necrosis, and the intrinsic/extrinsic apoptosis pathways — with the buzzwords, markers, and mechanisms boards reward.
Inflammation is the body's protective response to injury — acute (neutrophil-driven, vascular) versus chronic (macrophage-driven, fibrotic) — followed by wound healing through defined phases. This lesson locks down the leukocyte adhesion cascade, chemical mediators and their drug targets, granulomatous/adhesion defects, collagen chemistry, and the classic healing failures boards love to test.
A board-focused tour of neoplasia: multistep carcinogenesis, oncogenes vs tumor-suppressor genes, high-yield chemical and viral carcinogens, and the tumor markers (with next-best-step decisions) the USMLE loves to test.
A board-focused walkthrough of the four cellular adaptations — hypertrophy, hyperplasia, atrophy, and metaplasia — plus dysplasia, the preneoplastic bridge to cancer (not a true adaptation). Organized by mechanism (size vs. number vs. cell-type swap), classic organ examples, and the reversibility rule: everything is reversible until atypical cells invade through the basement membrane. Built around Step 1 vignettes (Barrett esophagus, postmenopausal bleeding) and next-best-step decisions.
A board-focused walkthrough of tissue repair: regeneration vs. scar, the ordered phases of wound healing with their cell types and collagen switches, growth-factor and nutrient biology, and the classic vignettes of impaired (scurvy, dehiscence) and excessive (keloid) healing.
A boards-focused walkthrough of the four core hemodynamic disorders — edema (Starling forces), thrombosis (Virchow's triad), embolism, and infarction — with classic vignette buzzwords, next-best-step decisions, and a red-vs-white infarct comparison.
A board-focused Step 1 lesson on amyloidosis covering the unifying β-pleated-sheet/Congo-red concept, the clinically important types (AL, AA, ATTR, Aβ2M), and the classic next-best-step logic for diagnosing and typing systemic and cardiac amyloid.
A high-yield Step 1 lesson on how tumors are graded (differentiation + mitoses) versus staged (TNM extent), why stage outweighs grade for prognosis, and the routes, classic patterns, and molecular steps of metastasis — the definitive hallmark of malignancy.
A high-yield tour of board-favorite environmental toxins (CO, cyanide, lead, arsenic, methanol, ethylene glycol) and nutritional deficiencies (fat-soluble and B vitamins, vitamin C), emphasizing classic vignette buzzwords, mechanisms, and next-best-step antidotes and supplements.
A board-focused walkthrough of intracellular accumulations (lipid, protein, glycogen, cholesterol), endogenous/exogenous pigments, and pathologic calcification, built around the highest-yield split — dystrophic vs metastatic calcification decided by the serum calcium level — with classic vignette buzzwords, next-best-step workups, and signature stains.
A Step 1–focused lesson on chronic and granulomatous inflammation: the macrophage/Th1 (IL-12→IFN-γ→TNF) mechanism, caseating vs. non-caseating differentials, giant-cell types, and buzzword vignettes for TB and sarcoidosis with explicit next-best-step decisions.
A Step 1–focused lesson on paraneoplastic syndromes: the classic tumor → mediator → syndrome triads (SIADH/Cushing/LEMS with SCLC, PTHrP hypercalcemia, ectopic EPO, MG/thymoma, anti-NMDA/ovarian teratoma), the vignette buzzwords, and the next-best-step decisions for diagnosis and management.
A boards-focused walkthrough of the pharyngeal apparatus — arches, pouches, clefts, and membranes — mapping each arch's cranial nerve, muscles, cartilage, and artery to the classic Step 1 syndromes (DiGeorge, Treacher Collins, branchial cleft cyst) and the recurrent laryngeal nerve.
A Step 1 walkthrough of the first three weeks of human development — fertilization, the bilaminar disc, and gastrulation — mapping each germ layer to its derivatives and the classic congenital defects (neural tube defects, sacrococcygeal teratoma, caudal regression, situs inversus) that boards test by mechanism and presentation.
Gastrulation converts the epiblast into three germ layers, each with a signature set of derivatives that boards probe through classic \"which layer?\" gotchas. This lesson maps ectoderm/mesoderm/endoderm (plus neural crest) to their derivatives and links neural-tube, neural-crest, pharyngeal-apparatus, and intermediate-mesoderm errors to the malformations Step 1 tests.
Traces cardiac development from the splanchnic-mesoderm heart tube through looping and septation, mapping each embryonic segment to its adult derivative, then ties the classic Step 1 congenital defects to the exact septation and neural-crest errors that cause them.
A Step 1 walkthrough of GI development — how the gut tube is divided into foregut, midgut, and hindgut by blood supply, what each segment becomes, and the four morphogenetic events (recanalization, herniation/rotation, pancreatic fusion, cloacal partition) whose failures produce the board-classic malformations: TEF, duodenal atresia, malrotation/volvulus, omphalocele vs gastroschisis, Meckel, and Hirschsprung — each with mechanism and presentation.
A Step 1 embryology lesson tracing the respiratory tree from the week-4 laryngotracheal diverticulum through the five stages of lung development, with the germ-layer derivatives, surfactant biology, and the board-favorite congenital defects (TEF/esophageal atresia, congenital diaphragmatic hernia, neonatal RDS, Potter-related pulmonary hypoplasia). Emphasis is on what goes wrong developmentally and how each malformation presents.
A Step 1 embryology lesson tracing CNS formation from notochord induction through neurulation, neuropore closure, and the 3→5 brain-vesicle sequence, then mapping each derivative and the board-favorite congenital malformations (NTDs, holoprosencephaly, Chiari II, Dandy-Walker) to their exact developmental mechanism and presentation.
A high-yield Step 1 walkthrough of sexual differentiation: the indifferent stage, the SRY switch, and the three hormones (AMH, testosterone, DHT) that build the male tract — with verified derivative and congenital-defect tables and paired CAIS vs. 5α-reductase vignettes.
A high-yield Step 1 walkthrough of face development (weeks 4–8, palate completing by ~week 12) from the five neural-crest-derived facial prominences and their derivatives, then the boards-favorite congenital clefts and first-arch anomalies — cleft lip vs. cleft palate, median/oblique clefts, and Pierre Robin sequence — each tied to its fusion-failure mechanism.
The pharyngeal (aortic) arch arteries — pairs 1, 2, 3, 4, and 6 (the 5th leaves no derivative) — remodel asymmetrically during weeks 4–8 into the definitive great vessels. Their failures generate the board's classic malformations: PDA (left 6th arch), coarctation of the aortic isthmus, interrupted arch (DiGeorge/22q11), and the vascular rings.
A high-yield STEP 1 walk through renal and genitourinary embryology: the three kidney stages and ureteric-bud/metanephric-mesenchyme induction, classic renal anomalies (agenesis/Potter, horseshoe, UPJ obstruction), and Wolffian vs Müllerian duct plus external-genitalia development with their signature defects. Anchored by comparison tables, two clinical vignettes, and the durable mnemonics (SEED, POTTER, DHT-outside/testosterone-inside).
A high-yield Step 1 embryology lesson tying together placental structure, twin chorionicity/amnionicity by splitting time, and the fetal circulatory shunts with their adult remnants. Includes twin-twin transfusion and prostaglandin/ductus vignettes plus classic mnemonics.
A board-focused tour of epithelial classification and the epithelial junctional complex — tight, adherens, desmosome, and gap junctions plus hemidesmosomes — mapping each junction's protein components to the high-yield blistering and genetic diseases (pemphigus vs. bullous pemphigoid, connexin mutations, E-cadherin loss) tested on Step 1.
A board-focused tour of connective tissue histology: its cells, fibers, and ground substance, then the high-yield collagen types, the step-by-step synthesis pathway, elastin, and the diseases (osteogenesis imperfecta, scurvy, Ehlers-Danlos, Marfan, Alport) that arise when a specific step fails.
A board-focused walkthrough of the three muscle types — how to identify skeletal, cardiac, and smooth muscle on histology, the sarcomere band anatomy and what changes during contraction, and the calcium-handling and intercalated-disc details Step 1 loves to test.
A Step 1–focused histology lesson on nervous tissue that maps neuron ultrastructure and axonal transport, then pairs each CNS/PNS glial cell with its origin, function, marker (GFAP, S-100), and disease. Reinforced with schwannoma and glioblastoma vignettes and classic transport/marker mnemonics.
A board-focused tour of the peripheral smear and bone marrow: identifying each formed element, the leukocyte-frequency mnemonic, and the classic morphologic buzzwords (hypersegmented neutrophils, Auer rods, schistocytes) that map to Step 1 diagnoses and next-best-steps.
A boards-focused walk through respiratory histology: the conducting-to-respiratory epithelial gradient, key cells (goblet, club, type I/II pneumocytes, macrophages, neuroendocrine), and the classic vignettes of neonatal RDS and Kartagener syndrome.
A board-focused walk through GI tract histology: the universal four-layer wall plan and enteric plexuses, the epithelial transitions and cell types of each segment, and the classic disease correlations (Barrett metaplasia, Hirschsprung aganglionosis, pernicious anemia).
A board-focused tour of reproductive histology anchored on gonadotropin targets and secretory products: Sertoli/granulosa (FSH) versus Leydig/theca (LH), the ovarian two-cell model, and classic buzzwords — Reinke crystals, Call–Exner bodies, stereocilia, and corpora amylacea — plus the clinical vignettes that test them.
A board-focused tour of skin histology: the five epidermal layers and their resident cells, dermal receptors and glands, and the two high-yield blistering diseases (pemphigus vulgaris vs bullous pemphigoid) defined by the junction protein targeted and the level of the split.
A high-yield Step 1 walkthrough of endocrine histology — pituitary, thyroid, parathyroid, adrenal, and pancreatic islet cell types with their hormones, embryologic origins, and the classic tumors and vignettes that test them.
A Step 1 high-yield lesson on cardiovascular histology that ties cardiac muscle, vessel-wall, and capillary structure directly to the diseases the boards test (ARVC, Marfan dissection, syphilitic aneurysm). Includes comparison tables, two clinical vignettes, and verified histology images.
A Step 1 histology lesson on the renal and urinary tract, centered on identifying nephron segments (PCT vs DCT), the three-layer glomerular filtration barrier and JGA, and the urothelium — anchored by classic board vignettes for minimal change disease and urothelial carcinoma.
The brachial plexus (C5–T1) and the five terminal nerves it spawns, mapped to the fractures, dislocations, and birth injuries that classically damage them — with the wrist-drop, ape-hand, claw-hand, benediction, and waiter's-tip signs that boards love to test, and the proximal-vs-distal lesion levels that change the picture.
A board-focused walkthrough of the 12 cranial nerves — modality, brainstem nucleus, exit foramen, and the signature lesion for each — anchored by the classic reflex arcs, ocular-motor palsies, and deviation rules Step 1 loves to test.
A Step 1–focused walkthrough of the lumbosacral plexus that maps each lower-limb nerve to its roots, motor and sensory territory, classic injury mechanism, and signature deficit/gait, anchored by high-yield vignettes (foot drop, Trendelenburg, meralgia paresthetica) and a mechanism → nerve reverse-lookup. Two comparison tables and the genuine anatomy mnemonics (PED/TIP, \"sound side sags,\" NAVEL) tie it together.
A high-yield Step 1 neuroanatomy lesson mapping the Circle of Willis and the ACA/MCA/PCA plus vertebrobasilar territories directly onto the deficits the boards test — cortical stroke patterns, brainstem syndromes, and the aneurysm/hemorrhage correlations. Built around the rule that knowing which artery feeds which cortex lets you predict every lesion.
A board-focused walkthrough of the three tested spinal cord tracts — dorsal columns, spinothalamic, and lateral corticospinal — anchored on where each decussates, then applied to the classic cord lesions (Brown-Séquard, syringomyelia, anterior spinal artery infarct, subacute combined degeneration, Friedreich ataxia, tabes dorsalis, and ALS).
A board-focused walk through the inguinal canal — its MALT walls, deep/superficial rings, and spermatic-cord coverings — building to the point exams test hardest: separating indirect, direct, and femoral hernias by their relation to the inferior epigastric vessels and the pubic tubercle, then covering the nerve injuries of hernia repair, the cremasteric reflex, and gonadal (para-aortic) vs scrotal (inguinal) lymphatic drainage.
A high-yield Step 1 anatomy lesson organizing the entire GI tract by its embryologic blood supply — foregut/celiac, midgut/SMA, hindgut/IMA — and deriving innervation, referred-pain maps, collateral/watershed circulation, and the classic ischemic, compression, and rotational-anomaly vignettes from that single scheme.
A Step 1 high-yield tour of cardiac anatomy — chamber/surface relations, coronary artery territories with their MI/ECG correlations, nodal blood supply and venous drainage, and pericardial anatomy — anchored to the injury and vignette patterns the boards actually test.
A board-focused tour of the mediastinum: the sternal-angle master landmark, the four divisions and their contents, and the high-yield clinical correlations — left recurrent laryngeal palsy, SVC syndrome, chylothorax, and the phrenic-anterior/vagus-posterior lung-root rule. Built for USMLE Step 1 vignettes.
A board-focused tour of the neck triangles: how the sternocleidomastoid partitions the neck, the key nerves and vessels each triangle contains, and the classic lesions (CN XI, recurrent vs. external laryngeal, hypoglossal) the USMLE loves to test.
A board-focused tour of autonomic anatomy: the two-neuron sympathetic (thoracolumbar) vs parasympathetic (craniosacral) wiring, the sympathetic chain with its splanchnic and adrenal-medulla pathways, the four cranial parasympathetic ganglia, and the classic lesion vignettes — Horner syndrome, compressive vs ischemic CN III palsy, Adie pupil, and Frey syndrome.
A board-focused tour of the vertebral column and spinal nerves: column organization and curvatures, the spinal-nerve exit rule and cord termination, dermatome/reflex root levels, and the high-yield clinical correlations — disc-herniation radiculopathies, cauda equina vs conus medullaris, and spinal cord tract syndromes.
A board-focused walkthrough of diaphragm anatomy — origins, crura, phrenic (C3–C5) innervation and blood supply, and the T8/T10/T12 openings — anchored to the classic Step 1 clinical correlations: phrenic palsy with an elevated hemidiaphragm, Kehr-sign referred shoulder pain, and congenital versus hiatal hernias.
A board-focused tour of pelvis and perineum anatomy: the pelvic floor and perineal pouches, the all-important pectinate line, the pudendal nerve and its blocks, urethral rupture patterns, and autonomic control of continence and sexual function — anchored to the clinical vignettes Step 1 loves.
A high-yield STEP 1 microbiology lesson on Gram-positive cocci that walks the boards' lab algorithm (morphology → catalase → coagulase/hemolysis → confirmatory tests) and maps each Staphylococcus and Streptococcus species to its virulence factors, classic vignette buzzwords, diseases, and treatment. Includes a full comparison table, vignette drills, a toxin deep-dive, post-strep sequelae, and only genuine, standard mnemonics (no fabricated acronyms).
A board-focused tour of the Gram-negative rods and Enterobacteriaceae: how to sort them by lactose fermentation, oxidase, urease, and H₂S, then the key toxins, buzzword vignettes, and treatments for each classic enteric plus Pseudomonas and the curved rods. Built for STEP 1 pattern recognition.
A board-focused tour of the gram-positive rods — the spore-formers Clostridium (anaerobic) and Bacillus (aerobic) plus Listeria and Corynebacterium — built around identifying lab clues, the single exotoxins that drive each disease, and the classic vignette buzzwords with first-line treatment. Includes a toxin-mechanism block, real micro mnemonics, and a master comparison table.
A high-yield Step 1 tour of the boards' favorite wall-less, intracellular, and spiral organisms — pairing each bug's identifying lab feature and classic vignette buzzword with the disease it causes and the correct drug. Covers the atypical-pneumonia group (Mycoplasma, Chlamydia pneumoniae/psittaci, Legionella, Coxiella) and the BLT spirochetes (Treponema, Borrelia, Leptospira).
A board-focused tour of the seven human DNA virus families (HHAPPPy), pairing each with its structural rules, cytopathic buzzwords, diseases, and antivirals. Anchored by high-yield herpesvirus and non-herpesvirus vignettes plus a comparison table.
A high-yield STEP 1 walkthrough of the RNA viruses, organized by the classification rules boards test (sense, segmentation, naked vs. enveloped, RdRp) and then by clinical system, with buzzword vignettes, classic mnemonics, and comparison tables covering families and the RNA hepatitis viruses.
A high-yield board-style comparison of hepatitis viruses A–E covering transmission, genome/structure, chronicity and cancer risk, HBV serology interpretation, classic vignette buzzwords, extrahepatic disease, and current treatment. Emphasizes the enteric vowels (A/E) vs. blood-borne B/C/D framework, HBV/HCV as the oncogenic pair, HDV's dependence on HBV, and HEV's danger in pregnancy.
A high-yield Step 1 tour of the medically important fungi — systemic dimorphic, opportunistic, and cutaneous/subcutaneous — pairing each organism's identifying morphology and lab clues with its classic vignette buzzwords and board-tested treatment, capped by an antifungal mechanism map. Corrected from the draft: coccidioidal meningitis is treated with high-dose fluconazole (not amphotericin B), and Pneumocystis uses a cholesterol membrane (so azoles/ampho B fail, hence TMP-SMX).
A CD4-count-driven tour of the AIDS-defining opportunistic infections the boards test, pairing each organism's identifying stain/morphology with its disease, classic vignette buzzword, and first-line treatment. Everything is anchored to the 200/100/50 threshold staircase and the CNS ring-enhancing-lesion differential.
A Step 1 high-yield micro lesson on bacterial toxins, genetics, and virulence — organizing exotoxin mechanisms (EF-2 ADP-ribosylation, ↑cAMP secretory, 60S/Shiga, SNARE proteases, superantigens), the exotoxin-vs-endotoxin contrast, gene transfer (transformation/transduction/conjugation, with lysogenic conversion carefully distinguished from specialized transduction), and non-toxin virulence factors, all tied to vignette buzzwords and current treatments. Includes verified Commons images and genuine classic mnemonics (ABCD'S, SHiN, the EF-2 pair).
A Step 1 high-yield microbiology lesson on antibiotic resistance mechanisms, organizing the four core strategies (enzymatic inactivation, target modification, reduced uptake/efflux, and pathway bypass) around the exam's favorite organisms — MRSA, VRE, ESBL/CRE, and resistant pneumococcus — with buzzword vignettes, a comparison table, and the β-lactam resistance ladder.
A high-yield Step 1 tour of medically important protozoa and helminths, organized by exposure/vector, pathognomonic buzzword, and first-line drug, with comparison tables and classic vignettes (amebic liver abscess, neurocysticercosis).
Heart failure split by ejection fraction: HFrEF (systolic, EF ≤40%) versus HFpEF (diastolic, EF ≥50%) — their distinct patients, exam signs (S3 vs S4), workup, and why only HFrEF has the mortality-reducing "four pillars" of GDMT (with SGLT2 inhibitors now benefiting both).
A board-focused walkthrough of acute coronary syndromes from plaque rupture to reperfusion, contrasting STEMI, NSTEMI, and unstable angina with the classic vignettes, ECG localization, next-best-step decisions, and the post-MI complication timeline. Emphasizes the high-yield twists boards test — RV infarct preload dependence, no lytics in NSTE-ACS, STEMI-equivalents (posterior MI, Sgarbossa-positive LBBB), and which therapies actually reduce mortality.
A Step 2 CK high-yield lesson on stable angina/chronic coronary disease covering supply–demand pathophysiology, the typical-angina criteria and pretest probability, the stress-testing decision tree, a chest-pain differential table (stable/unstable angina, NSTEMI, STEMI, vasospastic), and the split between symptom-relief and event-reducing therapy (COURAGE/ISCHEMIA and CABG survival indications).
A board-focused tour of the five tested valvular lesions — aortic stenosis/regurgitation, mitral stenosis/regurgitation, and mitral valve prolapse — linking each murmur and buzzword to its pathophysiology, echo findings, and next-best-step intervention. Includes maneuver tables, the acute-regurgitation surgical emergencies, and the crucial acute-vs-chronic AR distinction.
A board-focused walkthrough of bradyarrhythmias and heart block — from conduction anatomy and nodal-vs-infranodal localization through the ECG hallmarks of each AV block, classic vignettes (complete heart block, Lyme carditis), and the ACLS-to-pacemaker management pathway. Built around STEP 2 CK next-best-step decisions.
A board-focused walkthrough of tachyarrhythmias organized by the exam's own logic — narrow vs wide, regular vs irregular, stability first — covering SVT, atrial fibrillation/flutter, and VT with classic vignette buzzwords, ECG findings, and next-best-step management.
A board-focused walkthrough of the three cardiomyopathies—dilated, hypertrophic, and restrictive—linking pathophysiology to the classic vignette buzzwords, ECG/echo findings, and next-best-step decisions. Includes HCM murmur maneuvers, the cardiac-amyloid voltage–mass clue, and the restrictive-vs-constrictive discriminator.
A boards-focused walkthrough of the pericardial disease spectrum — acute pericarditis, effusion, tamponade, and constriction — emphasizing classic vignette buzzwords, ECG/echo findings, and next-best-step decisions. Includes three high-yield vignettes and a side-by-side comparison table.
A board-focused walkthrough of infective endocarditis from NBTE-to-vegetation pathogenesis through organism-by-setting microbiology, modified Duke diagnosis (2 major / 1 major + 3 minor / 5 minor), and next-best-step management, anchored by classic vignette buzzwords (Carvallo sign, FROM JANE stigmata, new AV block = aortic-root abscess). It drills the decisions boards test: cultures-then-empiric-vancomycin, TTE to TEE, and surgical indications.
A board-focused walkthrough of congenital heart disease: acyanotic left-to-right shunts, the cyanotic \"5 T's,\" ductus-dependent lesions and PGE1, with the classic vignette buzzwords, imaging clues, the failed hyperoxia test, syndrome associations, and next-best-step management.
A Step 2 CK high-yield lesson contrasting aortic aneurysm and aortic dissection across pathophysiology, presentation, diagnosis, and management, with board vignettes, buzzwords, and the key next-best-step decisions (imaging by stability, beta-blocker-before-vasodilator, and the 5.5 cm repair threshold).
A board-focused walk through dyslipidemia and atherosclerosis: LDL-driven plaque pathophysiology, the classic xanthoma/vignette buzzwords, inherited (Fredrickson) dyslipidemias, ACC/AHA statin benefit groups with LDL thresholds, risk-enhancing factors and CAC scoring, drug mechanisms/toxicities, and next-best-step management including hypertriglyceridemic pancreatitis.
A board-focused Step 2 CK lesson on hypertension covering 2017 ACC/AHA classification and diagnosis, when-to-treat thresholds driven by ASCVD risk, comorbidity-tailored drug selection, secondary-HTN pattern recognition, and hypertensive emergency vs urgency management. Built around classic vignette buzzwords and next-best-step decisions.
A five-step algorithm for reading any ABG — pH, primary driver, anion gap, compensation (Winter's), then the delta gap — packaged with the formulas, MUDPILES/HARDASS mnemonics, and the mixed-disorder vignettes (DKA, salicylates, vomiting) that Step 1 and CK reward.
A board-focused walkthrough of acute kidney injury that localizes each case to prerenal, intrinsic, or postrenal using BUN:Cr, FENa, and urine sediment, then drives the tested next-best-step and dialysis decisions. Emphasizes classic vignette buzzwords (muddy-brown casts, hyaline casts, eosinophiluria) and management reflexes.
A Step 2 CK high-yield lesson on chronic kidney disease covering hyperfiltration pathophysiology, KDIGO CGA staging, complications (anemia, CKD-MBD, acidosis, uremia), and guideline management, with board vignettes and next-best-step decisions on RAAS blockade, SGLT2 inhibitors, finerenone, and dialysis indications.
A board-focused walk through nephritic syndromes — inflammatory glomerular injury presenting with hematuria/RBC casts, hypertension, and azotemia — organized around the two exam discriminators (complement level and disease tempo) with classic buzzwords, RPGN emergencies, and next-best-step management.
A board-focused walkthrough of nephrotic syndrome: podocyte pathophysiology, the classic tetrad and its hypercoagulable and infectious complications, and the biopsy buzzwords, antibody tests, and next-best-step decisions that distinguish minimal change, FSGS, membranous, MPGN, diabetic, and amyloid disease.
A Step 2 CK-focused breakdown of hypo- and hyperkalemia covering pathophysiology (internal vs external balance), classic causes and ECG buzzwords, lab/urine localization, and the emergency next-best-step management ladders — stabilize → shift → eliminate for hyperkalemia, and replace K+ plus Mg for hypokalemia. Built around vignette buzzwords (U waves, peaked T waves) and the digoxin links boards love to test.
A Step 1-focused lesson on renal tubular acidosis that frames all types as a normal anion gap (hyperchloremic) metabolic acidosis and teaches the board discriminators — serum potassium, urine pH, and the urine anion gap — through a comparison table, classic vignettes, and next-best-step management. Corrected the urine anion gap teaching: it is positive in distal (Type 1) and Type 4 RTA but unreliable (often negative) in proximal (Type 2) RTA, which is identified by its Fanconi features instead.
A boards-focused walkthrough of nephrolithiasis — stone chemistry with classic crystal buzzwords, renal-colic presentation, CT-first diagnosis, and size-based plus emergency management — anchored on the high-yield infected-obstructed-stone next-best-step decision.
A Step 2 CK–focused review of UTI and pyelonephritis: ascending E. coli pathophysiology, urine dipstick and WBC-cast interpretation, cystitis vs pyelonephritis, and next-best-step antibiotic management—including the pregnancy and asymptomatic-bacteriuria treatment rules boards love to test.
A boards-focused walk through ADPKD and ARPKD — from the polycystin/fibrocystin ciliopathy mechanism to presentation, ultrasound-based diagnosis (Pei–Ravine criteria), classic extrarenal traps, and management including ACE inhibitors and tolvaptan. Built around vignette buzzwords and next-best-step decisions the way the boards test them.
Calcium and phosphate are governed by PTH, vitamin D, and FGF23 across gut, bone, and kidney — and boards test the lab pattern (Ca / PO₄ / PTH) more than any single value. This lesson walks the PTH-based workup of hyper- and hypocalcemia, the CHIMPANZEES causes, next-best-step management, and the phosphate/CKD-MBD picture.
A Step 2 CK-focused lesson linking renovascular hypertension (atherosclerotic RAS vs fibromuscular dysplasia) with hypertensive nephrosclerosis (benign vs malignant), built around RAAS pathophysiology, the ACEi/ARB creatinine-rise clue, the imaging ladder, and next-best-step management. It emphasizes board buzzwords (\"string of beads,\" \"flea-bitten kidney,\" \"onion-skin\") and correct hypertensive-emergency BP-lowering targets.
A Step 2 CK high-yield lesson on sodium and water disorders that frames dysnatremias as water problems and drives every case through serum osmolality, then volume status plus urine osmolality and urine Na — covering SIADH, diabetes insipidus, and the correction-rate rules that prevent osmotic demyelination and cerebral edema.
A boards-focused map of stroke syndromes: anterior-circulation (ACA/MCA/PCA) cortical patterns and lacunar syndromes, the medial-vs-lateral "rule of 4" for crossed brainstem syndromes (Wallenberg, AICA, medial medullary, locked-in), and the acute CT-then-thrombolysis/thrombectomy management pathway.
A boards-focused walkthrough of seizures and epilepsy — from excitation/inhibition pathophysiology and 2017 ILAE classification through syndrome-specific semiology, EEG signatures, and first-line drugs, to first-seizure workup and status epilepticus next-best-step decisions.
A Step 2 CK-focused headache lesson that walks pathophysiology → pattern recognition → diagnosis → acute and preventive management for migraine, cluster, and tension-type headache, with red-flag vignettes and next-best-step decisions for dangerous secondary causes.
A boards-focused neurology lesson on dementia and neurodegenerative disease, moving from proteinopathy pathophysiology through pattern-based localization, comparison of the major dementias (Alzheimer, vascular, Lewy body, frontotemporal, NPH, prion), and the classic next-best-step decisions tested on Step 1 and Step 2 CK.
A Step 1 pairing of Parkinson and Huntington disease as opposite ends of the basal ganglia circuit — pathophysiology, TRAP vs chorea presentation, Lewy bodies vs caudate atrophy, and levodopa vs VMAT2-inhibitor management, with next-best-step vignette logic and a side-by-side comparison.
A high-yield STEP 1/CK lesson on multiple sclerosis and the CNS demyelinating differential — pathophysiology, localization buzzwords (optic neuritis, INO, Lhermitte, Uhthoff), McDonald/MRI/CSF diagnosis, and next-best-step management including the classic NMOSD interferon trap.
A high-yield boards lesson on peripheral neuropathy patterns and Guillain-Barré syndrome, moving from pathophysiology and localization through CSF/NCS diagnosis to the emergency management decisions (respiratory monitoring, IVIG vs plasma exchange, and the classic steroid trap). Includes a GBS-vs-CIDP comparison, Miller Fisher recognition, and real vignette buzzwords with next-best-step logic. Reviewed and corrected for clinical accuracy: the myelin image was changed from a CNS oligodendrocyte to a Schwann-cell (peripheral) diagram to match GBS localization.
A board-focused walk through myasthenia gravis and Lambert–Eaton syndrome — pathophysiology (postsynaptic AChR vs presynaptic P/Q-type Ca²⁺ channel), the use-dependent weakness discriminator, antibody and electrodiagnostic diagnosis, tumor associations (thymoma vs small cell lung cancer), and next-best-step management including myasthenic crisis. Anchored by vignettes, a comparison table, and legitimate memory hooks.
A boards-focused walkthrough of CNS infection: distinguishing meningitis from encephalitis, reading the CSF, and driving the emergency next-best-step decisions — when to CT before LP, age-based empiric antibiotics plus dexamethasone, and empiric acyclovir for HSV encephalitis — anchored to classic vignette buzzwords (Waterhouse–Friderichsen, temporal-lobe HSV, Listeria, Cryptococcus).
A boards-focused tour of CNS tumors — from metastases and glioblastoma in adults to posterior-fossa pediatric tumors — pairing classic histology/imaging buzzwords with localization and next-best-step decisions. Emphasizes high-yield distinctions (medulloblastoma vs pilocytic astrocytoma, toxoplasmosis vs primary CNS lymphoma) and management pearls.
A localization-first tour of the classic spinal cord syndromes, using the crossing rules of the dorsal columns, corticospinal, and spinothalamic tracts to explain Brown-Séquard, anterior cord, central cord/syringomyelia, subacute combined degeneration, and tabes dorsalis. Includes board-style next-best-step decisions for cord compression, cauda equina, and epidural abscess.
A boards-focused walkthrough of raised ICP and herniation: Monro-Kellie physiology and the Cushing reflex, syndrome-by-syndrome localization, the CT-before-LP rule, and tiered next-best-step management including hyperosmolar therapy and decompression.
A board-focused walkthrough of cranial nerve palsies (III, IV, VI, VII) and vertigo, built around localization, classic vignette buzzwords, and next-best-step decisions—from the pupil-involving CN III aneurysm emergency to the HINTS exam for acute vestibular syndrome.
End-stage liver fibrosis produces two linked problems — hepatocellular synthetic failure and portal hypertension — and nearly every board fact (varices, ascites, SBP, encephalopathy, hyperestrinism, Child-Pugh/MELD) flows from one of them. This lesson maps the causes, portosystemic collaterals, decompensating complications, and next-best-step management.
A boards-focused walk through GERD and peptic ulcer disease — from LES failure and the acid-versus-mucosa imbalance to the classic duodenal-vs-gastric ulcer split, H. pylori testing rules, the dyspepsia next-best-step algorithm, eradication regimens, and the perforation/bleed/Zollinger-Ellison complications examiners love.
A boards-focused deep dive contrasting Crohn disease and ulcerative colitis across pathophysiology, presentation, diagnosis, and management—packed with vignette buzzwords, endoscopy/imaging/lab findings, and next-best-step decisions for STEP 1 and STEP 2 CK.
A Step 2 CK–focused walkthrough of acute pancreatitis from trypsin-driven autodigestion through the Revised Atlanta diagnostic criteria, etiology-directed workup, and current management (early moderate goal-directed fluids, early enteral feeding, no routine antibiotics). Emphasizes next-best-step decisions for gallstone pancreatitis and infected necrosis, plus high-yield comparison tables.
A high-yield STEP 1 / STEP 2 CK review of three esophageal disorders — achalasia, cancer (SCC vs adenocarcinoma), and varices — built around discriminating symptoms, gold-standard diagnostics, and next-best-step management. Emphasizes the classic board traps: pseudoachalasia, the solids-vs-liquids dysphagia rule, and the acute variceal-bleed bundle.
A boards-focused walkthrough of malabsorption: three-phase pathophysiology, deficiency-by-location clues, D-xylose logic, and the classic causes (celiac, Whipple, tropical sprue, pancreatic insufficiency, SIBO, abetalipoproteinemia) with next-best-step diagnosis and cause-directed management.
A high-yield board review of colorectal cancer and polyps covering the adenoma–carcinoma sequence and its three molecular pathways (APC/chromosomal instability, MSI/Lynch, serrated/BRAF), polyp and hereditary-syndrome comparison tables, right- versus left-sided presentation, current screening ages, and next-best-step diagnosis, staging, and management. Written for STEP 1 and STEP 2 CK with classic vignette buzzwords.
A boards-focused walkthrough of biliary disease from lithogenic bile to next-best-step management, mapping each syndrome (colic, cholecystitis, choledocholithiasis, cholangitis, gallstone pancreatitis) to its buzzwords, labs, imaging, and definitive intervention. Emphasizes ultrasound-first workup, HIDA for equivocal cholecystitis, and ERCP for CBD stones and cholangitis.
A high-yield Step 1 walkthrough of bilirubin metabolism and jaundice, anchored on the unconjugated-vs-conjugated fork and the five hereditary hyperbilirubinemias (Gilbert, Crigler-Najjar I/II, Dubin-Johnson, Rotor), with vignettes, a next-best-step work-up, and the neonatal jaundice buckets.
A high-yield Step 1/2 CK walkthrough of viral hepatitis (A–E) and autoimmune hepatitis, moving from pathophysiology to serology/autoantibody interpretation, classic vignettes, and next-best-step management. Emphasizes HBV serology (including the window period), HCV RNA confirmation before pangenotypic DAA therapy, and AIH diagnosis and steroid therapy.
A high-yield Step 2 CK lesson contrasting painless diverticular bleeding with painful diverticulitis — pathophysiology, presentation, CT-first diagnosis, and next-best-step management, including the antibiotic-selective shift for uncomplicated disease, Hinchey-guided surgery, and the lower-GI-bleed workup algorithm.
A Step 2 CK high-yield lesson on infectious diarrhea and colitis, organized around the inflammatory-vs-non-inflammatory framework with buzzword-to-bug associations, next-best-step decisions, and guideline-current C. difficile and EHEC/HUS management. Emphasizes when to withhold antibiotics and antimotility agents.
A Step 2 CK high-yield lesson pairing mesenteric ischemia (its four subtypes plus ischemic colitis) with acute appendicitis, driving each pathophysiology → presentation → diagnosis → NEXT-BEST-STEP with classic vignette buzzwords, imaging/lab findings, and comparison tables.
Uses the FEV1/FVC ratio to split obstructive disease (air trapping → low ratio, high lung volumes) from restrictive disease (small, stiff lungs → normal/high ratio, low TLC), then uses DLCO and the A–a gradient to sort the subtypes — the single highest-yield pulmonary PFT concept on Step 1.
A boards-focused Asthma vs COPD lesson running pathophysiology → presentation buzzwords → diagnosis (PFTs/imaging/ABG) → next-best-step management for STEP 1 and STEP 2 CK. Emphasizes reversibility testing, the falsely-normal PaCO2 trap, and GINA/GOLD-current therapy.
A boards-focused walkthrough of venous thromboembolism — from Virchow's triad and RV-strain pathophysiology through the Wells / D-dimer / CTPA diagnostic algorithm to next-best-step management, contrasting outpatient anticoagulation for low-risk PE with systemic thrombolysis for massive (high-risk) PE. Emphasizes classic vignette buzzwords and Step 1 / Step 2 CK decision points.
A Step 2 CK-focused lesson on pleural effusion and pneumothorax, moving from pleural-space pathophysiology through bedside exam, imaging, and pleural-fluid analysis to next-best-step management, anchored by Light's criteria, drainage thresholds, and the tension-pneumothorax crash vignette. Includes two comparison tables, two clinical vignettes, and classic memory hooks.
A boards-focused lung cancer lesson tracing pathophysiology (SCLC vs NSCLC subtypes, smoking/radon/asbestos risk) through presentation, paraneoplastic syndromes, diagnosis (LDCT screening, nodule workup, staging, preop PFTs), and stage-based management, anchored by classic vignettes and next-best-step decisions.
A board-focused tuberculosis lesson spanning pathophysiology (caseating granulomas, latent vs. reactivation disease), classic vignettes with next-best-step diagnosis (sputum AFB/NAAT/culture, TST-IGRA cutoffs, imaging), and RIPE-based management with drug toxicities. Targets STEP 1 mechanisms and STEP 2 CK decision-making.
A Step 2 CK-focused pulmonology lesson on ARDS and acute respiratory failure, moving from pathophysiology (diffuse alveolar damage, shunt physiology) through the Berlin diagnostic criteria and cardiogenic-edema differential to evidence-based ventilator management. Emphasizes classic vignette buzzwords and next-best-step decisions (intubation with lung-protective ventilation, BiPAP for hypercapnic failure, prone positioning for refractory hypoxemia).
A Step 1–2 walk through pulmonary hypertension and cor pulmonale — pathophysiology (PVR, remodeling, plexiform lesions), the 5 WHO groups, echo-then-right-heart-cath diagnosis, drug-suffix pathways, and group-specific management. Two board-classic vignettes (idiopathic PAH vs COPD cor pulmonale) drill the pre- vs postcapillary distinction and next-best-step decisions. Reviewed and verified against 2022 ESC/ERS thresholds; no mechanism, PFT/imaging, or next-best-step errors found.
A boards-focused walkthrough of obstructive sleep apnea from pharyngeal-collapse pathophysiology through polysomnography-based diagnosis and the CPAP-first management ladder, with STEP 2 CK next-best-step decisions, an OSA-vs-central comparison, and adult and pediatric vignettes.
A Step 1 high-yield lesson on interstitial lung disease and the pneumoconioses, moving from restrictive pathophysiology through PFT/imaging/lab diagnosis to management, anchored by classic vignette buzzwords, a UIP/IPF focus, and next-best-step decisions. Includes comparison tables (pneumoconioses; obstructive vs restrictive PFTs) and two verified Wikimedia figures.
A board-focused sarcoidosis lesson tracing pathophysiology (CD4⁺ Th1 noncaseating granulomas; macrophage 1α-hydroxylase → PTH-independent hypercalcemia; granuloma-derived ACE) through presentation, diagnosis (Scadding stages, restrictive PFTs with low DLCO, EBUS-TBNA biopsy, labs), and management, with classic buzzwords, named syndromes, and next-best-step vignettes for STEP 1 and STEP 2 CK.
A boards-focused walkthrough of cystic fibrosis and bronchiectasis: CFTR pathophysiology, the classic salty-infant and foul-sputum vignettes, sweat-chloride and HRCT diagnosis, and next-best-step management including CFTR modulators.
A high-yield Step 1/Step 2 CK lesson on pneumonia (typical, atypical, aspiration) and lung abscess, threading pathophysiology to next-best-step management through classic vignette buzzwords. Emphasizes host/exposure-driven organism selection, empiric therapy, and cavitary aspiration disease.
A boards-focused review of diabetes mellitus — separating type 1 from type 2, the diagnostic thresholds, and chronic complications — then a deep dive on diabetic ketoacidosis: pathophysiology, the classic vignette, the potassium trap, the ketone-testing pitfall, and DKA versus HHS.
A boards-focused walk through hypo- and hyperthyroidism, built around HPT-axis feedback: screen with TSH, confirm with free T4, then localize with antibodies/RAIU and pick the next best step (including Graves, thyroiditis, thyroid storm, and myxedema coma).
A Step 2 CK high-yield lesson on thyroid nodules and thyroid cancer, walking from pathophysiology through the TSH-first diagnostic algorithm (uptake scan for low TSH, FNA/Bethesda otherwise) to management, with the four cancer histologies, MEN2, and board buzzwords. Emphasizes next-best-step traps: hot nodules skip FNA, and pheochromocytoma must be excluded before medullary/MEN2 surgery.
A boards-focused walkthrough of Cushing syndrome and adrenal insufficiency: HPA-axis pathophysiology, the confirm-then-localize diagnostic sequence with dynamic testing, and next-best-step management (including adrenal crisis), anchored by classic vignette buzzwords and lab-comparison tables.
A boards-focused diagnostic and management comparison of pheochromocytoma (catecholamine excess) and primary hyperaldosteronism/Conn syndrome (autonomous aldosterone), built around the screen → confirm → localize → treat pathway, correct dynamic-test interpretation, and the two classic traps (alpha-before-beta blockade; drawing an ARR without prepping the patient).
A boards-focused walk through the three most-tested pituitary syndromes—acromegaly, prolactinoma, and hypopituitarism—emphasizing hormone-axis logic, dynamic testing, vignette buzzwords, and next-best-step decisions (hormone level first, MRI second; dopamine agonist before surgery for prolactinoma; glucocorticoid before levothyroxine).
A boards-focused walkthrough of calcium homeostasis and parathyroid disease: the PTH/vitamin D axis, the lab signatures that separate primary/secondary/tertiary hyperparathyroidism, FHH, hypoparathyroidism, and pseudohypoparathyroidism, plus the classic next-best-step decisions (check PTH first, urine calcium to exclude FHH, and when to operate).
A Step 1–focused walkthrough of MEN 1, 2A, and 2B — contrasting the menin tumor-suppressor (2-hit) versus RET oncogene (1-hit) mechanisms, then the organ-by-organ tumor patterns, dynamic hormone testing, classic vignettes (refractory ulcers + hypercalcemia; pheo-before-thyroidectomy), and management including risk-directed prophylactic thyroidectomy. Corrected the MEN1 pancreatic-NET framing (gastrinoma = most common functional tumor; metastatic pancreatic NETs = leading cause of death) and the MEN2B prophylactic-thyroidectomy timing (first 6 months of life per ATA highest-risk).
A Step 2 CK high-yield lesson on the chronic complications of diabetes, walking from hyperglycemic-injury pathophysiology through the ADA screening schedule to guideline-based, next-best-step management of retinopathy, nephropathy, neuropathy, and macrovascular disease. Emphasizes board buzzwords and decision points (UACR + ACEi/ARB/SGLT2i, PDR → panretinal photocoagulation, Kimmelstiel-Wilson nodules).
A boards-focused walkthrough of hypoglycemia and insulinoma — counterregulatory physiology and Whipple's triad, the hyperinsulinemic biochemical signature drawn during a 72-hour fast, and the C-peptide/ketone logic separating insulinoma from sulfonylurea, exogenous insulin, and IGF-2 tumors. Closes with localization and surgical/medical management, framed around the next-best-step decisions examiners test.
A high-yield Step 1/Step 2 CK lesson contrasting diabetes insipidus (too little ADH effect → dilute polyuria, hypernatremia) with SIADH (too much ADH → euvolemic hyponatremia), walking pathophysiology, dynamic testing, buzzword vignettes, a labs comparison table, and next-best-step management including sodium-correction limits.
A boards-focused walkthrough of carcinoid syndrome and neuroendocrine tumors — from serotonin pathophysiology and first-pass hepatic clearance through the classic flushing/diarrhea/right-heart presentation, 5-HIAA and DOTATATE workup, a functional-NET comparison table, and octreotide-centered management including carcinoid crisis.
A high-yield STEP 2 CK lesson on osteoporosis and metabolic bone disease covering DEXA/T-score criteria, screening and FRAX thresholds, a labs-based comparison of osteoporosis vs osteomalacia/Paget/hyperparathyroidism, and a drug table with two exam-style vignettes on fragility fracture and atypical femoral fracture.
A board-focused walk through the microcytic anemias — iron deficiency, anemia of chronic disease, thalassemia, and sideroblastic/lead — anchored on the classic iron-studies pattern, peripheral-smear clues, and the TAILS framework.
A Step 1 high-yield lesson linking macrocytic and hemolytic anemias by mechanism, walking pathophysiology → smear buzzwords → confirmatory labs/markers → next-best-step, with B12-vs-folate and hemolytic-anemia comparison tables and classic G6PD and pernicious-anemia vignettes.
A boards-focused walkthrough of the two hemoglobinopathy mechanisms — qualitative (sickle cell) versus quantitative (thalassemias) — mapping pathophysiology to smear and electrophoresis findings, classic vignette buzzwords, and next-best-step management for STEP 1 and STEP 2 CK.
A boards-focused walkthrough of acute leukemias: the shared marrow-failure presentation, then ALL vs AML separated by smear, flow markers, and cytogenetics, anchored to classic vignettes (APL with DIC, pediatric ALL) and next-best-step decisions.
A Step 1 high-yield lesson on the chronic leukemias, contrasting CLL (mature B-cell clone, smudge cells, CD5+/CD19+/CD23+) with CML (Philadelphia chromosome t(9;22)/BCR-ABL1, basophilia, low LAP), built around classic vignette buzzwords and next-best-step diagnostic and management decisions.
A board-accurate lesson on Hodgkin and non-Hodgkin lymphoma: Reed-Sternberg biology and HL subtypes, the key NHL entities with their defining translocations/markers/smear findings, and first-line/next-best-step management.
A boards-focused walkthrough of multiple myeloma and related plasma cell disorders — from the 'one clone, one antibody' pathophysiology and CRAB presentation through SPEP/free light chains, marrow criteria, and high-risk cytogenetics, with next-best-step vignettes and a MGUS/smoldering/MM/Waldenström comparison table.
A high-yield USMLE lesson on the BCR-ABL1–negative myeloproliferative neoplasms (PV, ET, PMF): JAK2/CALR/MPL driver biology, classic smear and lab buzzwords, EPO-based erythrocytosis triage, and next-best-step diagnosis and management. Structured patho → presentation → diagnosis → treatment with vignettes and a comparison table.</parameter> <parameter name="imageSuggestions">[{"commonsFile":"Polycythemia vera, blood smear.jpg","alt":"Peripheral blood smear from a patient with polycythemia vera showing increased, crowded red blood cells with mild anisopoikilocytosis","caption":"Polycythemia vera: a crowded peripheral smear reflecting increased red cell mass (Wright-Giemsa).","afterBlock":4},{"commonsFile":"Tear Drop Cells in PBS Microscopy.jpg","alt":"Peripheral blood smear showing teardrop-shaped red blood cells (dacrocytes) with elongated tapered ends","caption":"Teardrop cells (dacrocytes): the classic smear finding of primary myelofibrosis and marrow infiltration.","afterBlock":5}]
A high-yield STEP 1 review contrasting hemophilia A/B (factor VIII/IX deficiency, X-linked recessive, deep bleeding, isolated prolonged PTT that corrects on mixing) with von Willebrand disease (most common inherited bleeding disorder, mucocutaneous bleeding, prolonged bleeding time/PFA). It drills the lab reflexes, ristocetin logic, DDAVP-vs-concentrate decisions, inhibitor pitfalls, and classic next-best-step vignettes. Corrected the DDAVP mechanism: Weibel–Palade bodies store vWF (not factor VIII); DDAVP raises factor VIII indirectly via released vWF.
A boards-focused walkthrough of DIC as a consumptive coagulopathy — from tissue-factor pathophysiology through its schistocyte / low-fibrinogen / high-D-dimer lab signature to cause-directed, next-best-step management — anchored by classic obstetric and APL vignettes and a comparison table that separates DIC from TTP-HUS, ITP, liver failure, and vitamin K deficiency.
A high-yield USMLE review of inherited and acquired hypercoagulable states, pairing classic vignette buzzwords and lab clues (APC resistance, heparin-resistant PTT, non-correcting mixing study, PF4 antibodies) with next-best-step management. Includes a comparison table and two clinical vignettes (antiphospholipid syndrome and HIT).
A high-yield STEP 2 CK tour of the oncologic emergencies — tumor lysis syndrome, febrile neutropenia, malignant spinal cord compression, leukostasis, APL-associated DIC, hypercalcemia of malignancy, and SVC syndrome. Everything is framed around board-style next-best-step decisions, classic vignette buzzwords, and the labs/smear/marker patterns that separate one emergency from another.
A high-yield walkthrough of the destruction/consumption thrombocytopenias — ITP, TTP, HUS, HIT, and DIC — contrasting mechanism, smear and coagulation labs, and first-line management, anchored by TTP and HIT clinical vignettes.
A board-focused map of antibiotics organized by target — cell wall, ribosome, nucleic acid, folate, and membrane — with the bactericidal/bacteriostatic split, spectrum pearls (MRSA, Pseudomonas, atypicals, anaerobes), and the signature toxicities examiners love to test.
A boards-focused walkthrough of HIV/AIDS: virology and transmission, the CDC antigen/antibody diagnostic algorithm and window period, CD4-based opportunistic-infection staging, and modern antiretroviral therapy — with high-yield vignettes and next-best-step decisions.
A Step 2 CK–focused sepsis lesson covering Sepsis-3 definitions, the Hour-1 bundle, and exposure-driven organism/treatment reasoning, anchored by neutropenic-fever and septic-shock next-best-step vignettes. Emphasizes cultures-before-antibiotics, norepinephrine-first pressor management, and classic buzzwords (asplenia/OPSI, Vibrio, meningococcemia, toxic shock).
A Step 2 CK–focused lesson on healthcare-associated infections covering CLABSI, CAUTI, VAP/HAP, SSI, and C. difficile — organism, exposure clue, and next-best-step management for each, with board vignettes and current IDSA guidance. Emphasizes source control plus syndrome-tailored empiric coverage and the 2021 IDSA/SHEA update making fidaxomicin the preferred agent (oral vancomycin an acceptable alternative) for C. difficile.
A boards-focused Step 2 CK lesson on fever of unknown origin: the Petersdorf/Durack definitions and four etiologic buckets, exposure-driven organism matching, and next-best-step decisions anchored by classic vignettes (giant cell arteritis, adult-onset Still disease) and the staged diagnostic ladder ending in FDG-PET/CT and directed biopsy.
A boards-focused tour of the classic tick-borne infections — mapping vector, geography, and buzzword presentation to the next-best diagnostic and treatment step, anchored by the rule that doxycycline covers everything except Babesia.
A high-yield board review of malaria in the returning traveler — Plasmodium species and their exposures, the classic paroxysm and smear findings, thick/thin smear diagnosis with parasitemia grading, IV artesunate for severe disease, and primaquine/tafenoquine radical cure (after G6PD testing) for vivax/ovale — plus travel chemoprophylaxis and must-not-miss febrile differentials (typhoid, dengue).
A boards-focused walkthrough of skin & soft-tissue infections: the purulent-vs-nonpurulent and severity framework, exposure-specific organisms, classic buzzwords, and the next-best-step decisions — especially recognizing necrotizing fasciitis and choosing I&D versus antibiotics.
A board-focused walkthrough of infections in the immunocompromised host, organized by the failed immune arm (neutropenia, T-cell, humoral/asplenia, complement, CGD) and mapping each exposure clue to its classic organism, diagnosis, and next-best-step management. Emphasizes HIV CD4 thresholds, the transplant timeline, and high-yield decision points like empiric neutropenic-fever antibiotics, PCP steroid criteria, and when to start vs defer ART.
A board-focused walkthrough of TORCH congenital infections, pairing each organism's exposure clue and classic findings (calcification pattern, cardiac/ocular defects, rash distribution) with the tested next-best diagnostic step and current treatment. Emphasizes high-yield discriminators: CMV periventricular vs Toxo diffuse calcifications, urine/saliva CMV PCR within 3 weeks (treat only symptomatic disease), empiric IV acyclovir for neonatal HSV, aqueous penicillin G for congenital syphilis, spiramycin for maternal acute toxoplasmosis, and MCA Doppler for parvovirus B19 fetal anemia.
A boards-focused tour of vaccine-preventable diseases linking vaccine platform (and its contraindications) to classic vignette syndromes — measles, pertussis, diphtheria, tetanus, Hib epiglottitis, and rubella — with next-best-step decisions, the CDC tetanus wound algorithm, and post-exposure prophylaxis pearls. Corrected for currency: the live zoster vaccine (Zostavax) is retired in the US and replaced by recombinant Shingrix (RZV), which is non-live and preferred in immunocompromise.
A board-focused tour of the helminths (nematodes, cestodes, trematodes) and the key parasitic protozoa, mapping each classic exposure and buzzword to its diagnosis, confirmatory test, and first-line therapy. The lesson anchors on the high-yield treatment clusters (albendazole/ivermectin vs. praziquantel vs. metronidazole) and on next-best-step decisions like screening for Strongyloides before immunosuppression.
A Step 2 CK–focused tour of antimicrobial prophylaxis across three arenas — surgical, post-exposure, and HIV opportunistic-infection — paired with stewardship decisions, including the high-yield traps of when NOT to give antibiotics (asymptomatic bacteriuria, viral URIs) and how to avoid C. difficile.
A Step 1-focused walkthrough of the menstrual cycle: the HPO axis and two-cell theory, the biphasic estrogen feedback switch that drives the LH surge and ovulation, and the fixed 14-day luteal phase — plus the hormone effects and clinical cues boards love to test.
A boards-focused walkthrough of amenorrhea and abnormal uterine bleeding — from HPO-axis and outflow-tract pathophysiology through the reflex next-best-steps: β-hCG first, FSH-based localization, the breast × uterus grid, PALM-COEIN, and \"postmenopausal bleeding = endometrial cancer until proven otherwise.\"
A boards-focused PCOS lesson tracing pathophysiology (↑LH:FSH plus insulin resistance) through Rotterdam diagnosis-of-exclusion, tumor red flags, and goal-directed management, anchored by next-best-step vignettes and a hyperandrogenism differential table. Emphasizes high-yield exam pivots: unopposed-estrogen endometrial risk, testosterone/DHEA-S tumor cutoffs, and letrozole as first-line ovulation induction.
A high-yield Step 2 CK review of contraception covering effectiveness tiers (LARC first-line), the estrogen contraindications that dominate the exam (MEC category 4), emergency-contraception selection by timing and BMI, and classic IUD management pearls. Structured around next-best-step decisions with vignette buzzwords.
A high-yield STEP 2 CK lesson on menopause and hormone therapy, moving from the pathophysiology of follicular depletion and rising FSH through classic vignette presentations to guideline-based next-best-step management. Emphasizes the postmenopausal-bleeding-equals-endometrial-cancer rule, unopposed-estrogen risk, HT timing/contraindications, and non-hormonal alternatives.
A boards-focused pairing of cervical cancer (HPV-driven, screenable, prevented by vaccine, presents with postcoital bleeding) against ovarian cancer (BRCA/tubal-origin, no screening, late vague presentation, most lethal), emphasizing next-best-step decisions, classic markers, and buzzword histology.
A high-yield board review of breast disease from benign lesions through breast cancer — pathophysiology, classic vignette buzzwords, age-based workup, current screening, and next-best-step management calibrated for Step 1 and Step 2 CK.
A high-yield board review of the major STIs — chlamydia, gonorrhea, syphilis, HSV, chancroid, LGV, granuloma inguinale, and trichomoniasis — plus pelvic inflammatory disease, emphasizing buzzword-to-organism matching, comparison tables, and next-best-step management per current (2021) CDC guidelines. Covers STEP 1 pathophysiology and STEP 2 CK diagnosis and treatment decisions.
A high-yield walkthrough of male GU disease anchored to prostate zonal anatomy — BPH, acute prostatitis, and adenocarcinoma — plus the acute scrotum (torsion vs epididymitis) and painless testicular masses, emphasizing next-best-step decisions and classic vignette buzzwords. Built for STEP 1 and STEP 2 CK.
A Step 2 CK high-yield lesson on early-pregnancy emergencies, walking ectopic pregnancy and spontaneous abortion from pathophysiology through β-hCG/TVUS diagnosis to next-best-step management, anchored by stable-vs-unstable vignettes, a cervical-os comparison table, and board decision rules.
A high-yield board lesson contrasting endometriosis, adenomyosis, and uterine leiomyomas by tissue location and exam findings, then walking pathophysiology to presentation to diagnosis to management with classic vignette buzzwords and fertility-keyed next-best-step decisions. Anchored by a side-by-side comparison table and two clinical vignettes.
A board-focused walkthrough of disorders of sexual development — the SRY → AMH/testosterone → DHT differentiation cascade, then AIS, 5α-reductase deficiency, MRKH, and the CAH enzyme blocks — emphasizing classic vignette buzzwords and next-best-step decisions like 17-OHP screening, karyotyping, electrolyte rescue, and timing of gonadectomy.
A boards-focused walkthrough of the infertility evaluation: assessing both partners across sperm, ovulation, ovarian reserve, and tubal patency, anchored by the WHO ovulatory classification, PCOS/tubal-factor/hypothalamic vignettes, and classic next-best-step calls (semen analysis first, HSG for tubal factor, letrozole first-line for PCOS).
A high-yield psych lesson mapping each antidepressant class to its signature board pearls, then drilling the serotonin syndrome triad, its cyproheptadine-based management, and the classic distinctions from NMS and TCA overdose. Emphasis throughout is on the diagnosis and \"next best step\" the boards reward.
A boards-focused lesson on antipsychotic movement complications: the four extrapyramidal symptoms with their \"rule of 4s\" timeline and treatments, plus recognition and next-best-step management of neuroleptic malignant syndrome, including how to distinguish it from serotonin syndrome and malignant hyperthermia.
Board review of unipolar (MDD, persistent depressive disorder) vs bipolar-spectrum mood disorders, emphasizing DSM-5 symptom counts/durations, first-line pharmacotherapy, and the next-best-step decisions boards test. Centered on the pivotal question of any prior manic/hypomanic episode, which reclassifies the illness and reshapes management. Reviewed for accuracy: DSM-5 criteria, drug pitfalls, and serotonin-syndrome/NMS contrast confirmed correct; the one substantive fix was Vignette 1's manic-episode duration (6 days corrected to an unambiguous 8 days ≥1 week to secure the Bipolar I diagnosis).
A board-focused review of DSM-5 anxiety disorders (GAD, panic disorder, specific phobia, social anxiety, agoraphobia): exact durations and symptom-count criteria, the medical/substance mimics to exclude first, classic vignettes, and first-line SSRI/SNRI-plus-CBT management with next-best-step calls (benzo bridge, buspirone, PRN propranolol).
A boards-focused tour of schizophrenia and the psychotic-disorder spectrum: DSM-5 criteria and the duration cutoffs that separate them, classic vignette buzzwords, first-line atypical antipsychotics through clozapine for refractory disease, and next-best-step handling of EPS and NMS.
A board-focused Step 2 CK review of OCD and its related disorders (BDD, hoarding, trichotillomania, excoriation): DSM-5 criteria and the ">1 hour/day" rule, epidemiology, classic vignette buzzwords, SSRI-plus-ERP management with next-best-step decisions, and the high-yield OCD-vs-OCPD distinction. Clinically verified against DSM-5 and standard board pharmacology.
A high-yield STEP 2 CK lesson on PTSD and trauma-related disorders, anchored on the DSM-5 duration rules (acute stress disorder 3 days–1 month vs. PTSD >1 month vs. adjustment disorder, onset ≤3 months) with the 4 symptom clusters, epidemiology, first-line therapy/meds (trauma-focused CBT/EMDR; sertraline and paroxetine — the only FDA-approved agents — plus venlafaxine/fluoxetine; prazosin for nightmares), drugs to avoid (benzodiazepines, routine debriefing), and classic next-best-step traps.
A boards-focused tour of the 10 DSM-5 personality disorders across Clusters A/B/C — general PD criteria plus the key durations (only antisocial strictly requires age ≥18, with conduct disorder before 15; other PDs may be diagnosed under 18 if features persist ≥1 year), classic vignette buzzwords, commonly-tested look-alike distinctions, and first-line management (psychotherapy for all; DBT for borderline; no FDA-approved drug for a PD itself). Emphasizes ego-syntonic traits and high-yield next-best-step decisions.
A boards-focused walkthrough of DSM-5 substance use disorder criteria and the major intoxication and withdrawal syndromes, emphasizing withdrawal timelines, first-line pharmacotherapy, and high-yield next-best-step decisions for alcohol, opioids, sedatives, stimulants, and nicotine.
A high-yield Step 2 CK walkthrough of the DSM-5 eating disorders—anorexia, bulimia, and binge-eating disorder (plus ARFID)—emphasizing the tested durations, buzzword presentations, and next-best-step management including first-line therapy and medications. Built around comparison tables and classic vignettes so the differentiators (weight, compensatory behavior, electrolytes) map directly to exam decisions. Clinical accuracy verified: DSM-5 criteria/durations, BMI severity bands, first-line drugs (fluoxetine 60 mg for BN, lisdexamfetamine for BED, olanzapine adjunct for AN), the bupropion contraindication, and refeeding-syndrome mechanism all confirmed correct.
A Step 2 CK–focused walkthrough of DSM-5 somatic symptom and related disorders — criteria, durations, and epidemiology — with vignette buzzwords and next-best-step management, plus the factitious-vs-malingering framework and the insulin/C-peptide pearl. Corrected the SSD onset claim (no DSM-5 age criterion), clarified that factitious disorder imposed on another is diagnosed in the perpetrator, and verified all durations, first-line treatments, and the hypoglycemia lab triad.
A boards-focused tour of child & adolescent psychiatry: DSM-5 criteria with exact durations/onset, epidemiology, buzzword vignettes, and first-line management for ADHD, autism spectrum disorder, ODD, and conduct disorder — built around the next-best-step decisions examiners test.
A high-yield STEP 2 CK psychiatry lesson on delirium and DSM-5 neurocognitive disorders, covering diagnostic criteria and durations, subtype buzzwords, and next-best-step management with board-style vignettes.
A boards-focused Rheumatoid Arthritis lesson tracing pathophysiology (citrullination, anti-CCP/RF, pannus, RANKL erosions) through classic presentation, diagnosis (autoantibodies, inflammatory synovial fluid, erosive imaging), and treat-to-target DMARD management. Emphasizes vignette buzzwords, RA-vs-OA contrasts, and next-best-step decisions like TB and hepatitis screening before TNF inhibitors.
A board-focused MSK/rheumatology lesson contrasting osteoarthritis (degenerative), gout (MSU crystals), and pseudogout (CPPD crystals) across pathophysiology, presentation, synovial fluid and imaging, and next-best-step management. Emphasizes arthrocentesis to exclude septic arthritis, birefringence patterns, negative autoantibodies, and the rule against starting urate-lowering therapy during an acute flare.
Board-focused SLE and antiphospholipid syndrome: the type III/type II immune-complex pathophysiology, buzzword presentations (malar rash, nonerosive arthritis, Libman–Sacks), the autoantibody panel and synovial-fluid/imaging clues that clinch the diagnosis, and next-best-step management — plus APS's clotting paradox (prolonged aPTT that won't correct, false-positive VDRL) and its warfarin-not-DOAC treatment.
A high-yield overview of the HLA-B27-associated seronegative spondyloarthropathies (ankylosing spondylitis, reactive, psoriatic, and enteropathic arthritis), covering shared IL-23/IL-17 pathophysiology, classic vignette buzzwords, sacroiliac imaging and synovial-fluid workup, and the NSAID → DMARD → biologic management ladder with board-style next-best-step decisions.
A boards-focused tour of the systemic vasculitides organized by Chapel Hill vessel size, pairing each disease with its antibody, buzzwords, and imaging. It drills the high-yield next-best-step decisions—steroids-before-biopsy in giant cell arteritis and rituximab-based induction in ANCA-associated disease.
A Step 1–focused, clinically verified lesson on three antibody-defined connective tissue diseases — Sjögren, systemic sclerosis (limited/CREST vs diffuse), and MCTD — emphasizing signature autoantibodies, buzzword vignettes, and next-best-step decisions like ACE inhibitors for scleroderma renal crisis. Includes a comparison table, the standard CREST mnemonic, and two verified Commons images.
A board-focused MSK/rheumatology lesson on osteomyelitis and septic arthritis, moving from pathophysiology and organism-by-scenario buzzwords through synovial fluid analysis, imaging, and next-best-step management. Emphasizes arthrocentesis as the pivotal test, empiric vancomycin ± ceftriaxone, and crystal/reactive-arthritis mimics.
A boards-focused walk through primary bone tumors, sorted by the three clues that crack every vignette — patient age, location within the bone, and radiographic buzzwords — with osteosarcoma and Ewing sarcoma vignettes and the mandatory biopsy-before-treatment workup. Emphasizes imaging signs, genetics, RANKL/PGE2 mechanisms, and next-best-step decisions.
A high-yield Step 2 CK review of common fractures and orthopedic injuries — classic eponyms, fracture-associated nerve/vessel injuries, and the "next best step" for board emergencies including occult scaphoid fracture, compartment syndrome, open fracture, and fat embolism.
A Step 1 high-yield lesson contrasting Paget disease (isolated ↑ALP, normal Ca/phosphate, mosaic bone, IV bisphosphonate first-line) with vitamin D–deficient osteomalacia and rickets (↓Ca, ↓phosphate, ↑ALP, ↑PTH via secondary hyperparathyroidism), organized around the Ca/phosphate/ALP/PTH panel with classic radiographic buzzwords and next-best-step decisions. It explicitly notes these metabolic bone diseases lack diagnostic autoantibodies and synovial-fluid findings. Reviewed for clinical accuracy: mechanisms, lab patterns, and first-line management verified; all three Wikimedia Commons image files confirmed to exist.
A Step 2 CK-focused lesson on fibromyalgia (central sensitization, normal labs, exercise + duloxetine/amitriptyline first-line, avoid opioids) and common soft-tissue disorders, using classic vignette buzzwords, next-best-step logic, and comparison tables for the chronic-widespread-pain differential and synovial fluid analysis.
A high-yield USMLE lesson on polymyositis and dermatomyositis covering the proximal-weakness pattern, CK/EMG findings, DM skin signs, myositis-specific antibodies, malignancy and ILD associations, biopsy/mechanism, key mimics, and treatment. Seven blocks: two prose, one highYield, two clinical vignettes, and two tables (autoantibodies plus a PM-vs-DM comparison). Verified accurate; the highYield now includes the top-tested DM-vs-PM biopsy/immunology contrast.
A boards-focused walkthrough of eczematous (spongiotic) dermatitis — atopic dermatitis (filaggrin loss-of-function + Th2/IgE), and irritant vs allergic (Type IV) contact dermatitis — emphasizing classic morphology buzzwords, distribution by age, patch-test diagnosis, next-best-step management, and the eczema herpeticum emergency. Includes a comparison table, two vignettes, and the standard ACID hypersensitivity mnemonic.
Board-focused review of psoriasis and the papulosquamous differential (lichen planus, pityriasis rosea, pityriasis rubra pilaris, secondary syphilis): classic morphology, bedside signs, histology/DIF buzzwords, high-yield associations, and the stepwise treatment ladder — anchored by the two exam traps (avoid systemic steroids in plaque psoriasis; rule out syphilis when palms/soles are involved).
A high-yield Step 1/Step 2 CK dermatology lesson on the three major skin cancers, moving from UV-driven pathophysiology through classic morphology, biopsy choice, metastatic risk, and next-best-step management for BCC, SCC, and melanoma. Clinically reviewed: the draft was largely accurate; the only substantive fix corrects the melanoma growth line (radial/horizontal phase is low-risk but not synonymous with in situ), with minor precision edits (thymine-dimer wording, keratoacanthoma as well-differentiated SCC, HMB-45 specificity, BRAF prevalence). No fake mnemonics or invented facts were present. All three Wikimedia Commons images were verified to exist and match their captions.
A high-yield Step 1 comparison of pemphigus vulgaris (anti-desmoglein 3, intraepidermal/suprabasal split, flaccid bullae, Nikolsky positive, "fishnet" DIF) versus bullous pemphigoid (anti-BP180/BP230, subepidermal split, tense bullae, Nikolsky negative, linear IgG+C3 DIF), built around board vignettes, biopsy/immunofluorescence buzzwords, and next-best-step management.
A boards-focused tour of bacterial (impetigo, erysipelas, cellulitis, SSSS, necrotizing fasciitis) and viral (HSV, VZV, molluscum) skin infections, organized by tissue depth and buzzword morphology, with vignettes drilling next-best-step decisions and comparison tables for depth-based bacteria and SSSS vs. TEN.
A boards-focused walkthrough of superficial fungal (dermatophyte, Malassezia, Candida) and parasitic (scabies, cutaneous larva migrans, lice) skin infections, pairing classic vignette buzzwords and KOH/scraping findings with next-best-step management for STEP 1 and STEP 2 CK.
A boards-focused dermatology lesson contrasting acne vulgaris and rosacea from pathophysiology through morphology, diagnosis, and stepwise management, anchored on the comedone-based acne-vs-rosacea discriminator and the isotretinoin workup. Emphasizes NEXT-BEST-STEP decisions tested on STEP 2 CK.
A boards-focused dermatology lesson on severe cutaneous adverse drug reactions, contrasting SJS/TEN (painful mucocutaneous sloughing, granulysin-driven keratinocyte apoptosis) with DRESS (long-latency morbilliform rash with facial edema, eosinophilia, HHV-6 reactivation, and organ injury). Emphasizes classic vignette buzzwords, latency-based discrimination, HLA pharmacogenetics, biopsy/DIF findings, and next-best-step management.
A Step 1–focused dermatology lesson on pigmentation disorders, organized by mechanism (melanocyte loss vs. defective melanin synthesis vs. hormonal/UV-driven hyperpigmentation), with classic vignette buzzwords, comparison tables, and next-best-step decisions. Covers vitiligo, albinism, pityriasis versicolor, café-au-lait syndromes, melasma, Addison pigmentation, and the melanoma ABCDE rule.
A board-focused tour of the skin findings that betray internal disease — metabolic/endocrine markers, paraneoplastic dermatoses, neutrophilic and IBD-associated eruptions, connective-tissue and vascular signs, and neurocutaneous syndromes — pairing each classic morphology buzzword and immunofluorescence/biopsy clue with the next-best diagnostic step it demands.
A Step 1 high-yield tour of the phakomatoses (NF1, NF2, tuberous sclerosis, Sturge-Weber, VHL, plus ataxia-telangiectasia), pairing each signature skin lesion with its CNS/visceral tumor, its gene/protein/mechanism, and the tested next-best-step. Includes a genetics table, four vignettes, morphology buzzwords, and accurate memory anchors.
A high-yield Step 1 lesson separating superficial-dermal urticaria from deep angioedema, contrasting histamine-mediated (allergic) with bradykinin-mediated (ACE-inhibitor and hereditary C1-INH deficiency) swelling, and HSV-triggered erythema multiforme target lesions from drug-induced SJS/TEN.
A boards-focused walkthrough of community-acquired pneumonia: the CXR-confirmed diagnosis, typical vs. atypical organism buzzwords, CURB-65 disposition, and the 2019 ATS/IDSA empiric antibiotic tiers — all anchored to the "next best step" the exam rewards.
A boards-focused, stepwise approach to hyponatremia — serum osmolality → volume status → urine osm/Na⁺ — anchored on SIADH, the euvolemic mimics, and the safe rate of correction. Emphasizes the exact \"next best step\" (workup vs. management) and the osmotic demyelination guardrails STEP 2 CK loves to test.
A board-style approach to chest pain that rules out the six immediate killers first — anchored on the 10-minute ECG — then drills the buzzword-to-next-step decisions for ACS, aortic dissection, PE, cardiac tamponade, and their common mimics.
A board-focused framework for dyspnea that sorts patients into cardiac, pulmonary, and other causes and drives the next-best-step from vitals, ECG, CXR, BNP, D-dimer, and troponin. It anchors on classic vignette clues (orthopnea/PND, sudden pleuritic pain, Kussmaul breathing) and on when to stabilize before imaging.
A board-focused framework for acute abdominal pain: characterize the pain, stabilize unstable or peritonitic patients and check a β-hCG first, then let location drive the top diagnosis, best initial test, and management across the classic acute-abdomen emergencies.
A board-focused framework for syncope: separate benign reflex and orthostatic causes from life-threatening cardiac syncope using history, exam, orthostatic vitals, and a mandatory 12-lead ECG, then apply next-best-step diagnosis and disposition rules.
A board-style algorithmic walkthrough of the anemia workup built on two axes — MCV (cell size) and reticulocyte count (marrow response) — with iron-study interpretation, the microcytic and megaloblastic differentials, hemolysis labs, and the classic \"next best step\" decisions Step 2 CK tests.
A board-focused walkthrough of frailty as a syndrome of lost physiologic reserve — the Fried phenotype, the 5 Ms, and the geriatric giants (falls, delirium, polypharmacy) — with next-best-step deprescribing and function-focused management for Step 2 CK.
A Step 2 CK–focused walkthrough of USPSTF cancer screening (breast, cervical, colorectal, lung, prostate) plus core adult preventive care, emphasizing exact ages/intervals, next-best-step decisions, and when NOT to screen.
A board-style, next-best-step approach to edema: anchor on Starling mechanisms, then triage by distribution (unilateral/local vs bilateral/systemic) and pitting vs non-pitting, using JVP, urinalysis, and the drug list to name the organ. Includes classic DVT, heart-failure, and nephrotic-syndrome vignettes with management by cause.
A board-focused, integrative Step 2 CK lesson on evaluating lymphadenopathy with unintentional weight loss — sorting reactive from malignant nodes, recognizing lymphoma B symptoms and the Virchow node, and choosing the correct next diagnostic step (excisional biopsy vs FNA).
A board-focused framework for altered mental status: stabilize ABCs, check a fingerstick glucose, and give universal reversibles while working the AEIOU-TIPS differential — then anchor on the classic next-best-step vignettes (hepatic encephalopathy, Wernicke, opioid toxicity, and delirium management).
A Step 2 CK–focused lesson on the hypertensive-disorders-of-pregnancy spectrum — diagnostic criteria, severe features, magnesium prophylaxis, acute BP control, and delivery timing — built around the \"next best step\" the boards test.
A Step 2 CK lesson on normal labor and the stages of delivery: the three stages with their board-tested time limits, the current ACOG 6 cm active-phase threshold and arrest criteria, distinguishing protraction from arrest, the cardinal movements, fetal deceleration interpretation (VEAL CHOP), and the "next best step" for stalled labor and non-reassuring tracings.
High-yield Step 2 CK review of routine prenatal care: the screening timeline by gestational age, aneuploidy/NTD serum-marker patterns, and next-best-step management for gestational diabetes, group B Strep, and Rh isoimmunization.
A Step 2 CK–focused walkthrough of gestational diabetes: hPL-driven insulin resistance, the two-step vs one-step screening/diagnosis pathway, diet-then-insulin management with glucose targets, and delivery/postpartum decisions — anchored by the classic board discriminator that GDM (unlike pregestational DM) causes no congenital anomalies. Every cutoff and next-best-step verified against ACOG standards.
A board-focused breakdown of the two classic causes of third-trimester bleeding — painless placenta previa vs. painful placental abruption — covering risk factors, presentation, the no-vaginal-exam-before-ultrasound rule, and next-best-step management, plus vasa previa and placenta accreta spectrum as don't-miss differentials.
A Step 2 CK–focused lesson on postpartum hemorrhage built around the 4 T's, emphasizing bedside uterine assessment, uterotonic contraindications, and next-best-step management from massage through hysterectomy.
A board-focused walkthrough of abnormal labor — the 3 Ps, protraction versus arrest criteria (including the ≥200 MVU rule and when to choose cesarean over oxytocin) — paired with NICHD fetal heart rate interpretation, the three decelerations, and their next-best-step management.
High-yield STEP 2 CK lesson on preterm labor and PROM/PPROM: confirm the diagnosis at the bedside, then choose the next-best step by gestational age and infection status, anchored on the recurring answer set of corticosteroids, magnesium, GBS prophylaxis, and latency antibiotics. Draft was clinically strong; corrections tightened the indomethacin adverse-effect profile, specified betamethasone for the late-preterm course, clarified intrapartum GBS dosing, and added anaerobic coverage for chorioamnionitis at cesarean.
A board-focused walkthrough of pregnancy infections in two buckets: congenital TORCH pathogens (buzzwords, calcification patterns, screening) and peripartum bacterial infections (GBS prophylaxis, chorioamnionitis, antibiotic safety), anchored by next-best-step vignettes.
A Step 2 CK–focused walkthrough of multiple gestation: chorionicity (not zygosity) determines risk, monochorionic placentation drives TTTS and related syndromes, and delivery timing and mode follow chorionicity plus the presenting twin's lie.
A board-focused walkthrough of the three vaginitides (bacterial vaginosis, candidiasis, trichomoniasis) and cervicitis (chlamydia, gonorrhea), driven by classic buzzwords and pH/microscopy/NAAT decision points toward next-best-step management.
A Step 2 CK high-yield walkthrough of acute pelvic pain and adnexal masses, built as a decision tree (β-hCG first → acute vs chronic → TVUS → stability → age/malignancy risk) with next-best-step vignettes for ovarian torsion and ectopic pregnancy.
A boards-focused approach to the acute abdomen: use pain type, peritoneal signs, and hemodynamics to separate surgical emergencies from medical mimics, then apply the classic buzzword → next-best-step reflexes (unstable + peritonitis = OR; βhCG first; free air = perforation; pain out of proportion = mesenteric ischemia).
A STEP 2 CK–focused lesson distinguishing small- from large-bowel obstruction by cause, presentation, and imaging, drilling the \"next best step\" boards love — conservative \"drip and suck\" vs. emergent surgery for strangulation, endoscopic detorsion for sigmoid volvulus, and telling mechanical obstruction from functional mimics (ileus, Ogilvie).
A boards-focused walkthrough of the ATLS primary (ABCDE) and secondary surveys, drilling next-best-step decisions for the immediate thoracic killers, hemorrhagic-shock classification, and the airway-before-everything priority rule.
A board-focused Step 2 CK lesson on burn management: airway-first triage, depth and TBSA assessment, Parkland fluid resuscitation titrated to urine output, CO/cyanide toxicity, escharotomy, topical antimicrobials, and burn-center transfer criteria — anchored by next-best-step vignettes.
A Step 2 CK-focused walkthrough of perioperative care: cardiac risk stratification (METs, RCRI, surgical timing), which drugs to hold or continue, and the postoperative-day timeline that pins down post-op fever and surgical complications with next-best-step management.
A high-yield STEP 2 CK vascular surgery lesson covering AAA, PAD, and acute limb ischemia, organized around board-style buzzwords and next-best-step decisions with size/ABI thresholds and the stable-vs-unstable management fork.
A Step 2 CK-focused walkthrough of hepatobiliary and pancreatic surgery, organizing gallstone complications, acute pancreatitis, and pancreatic cancer around ultrasound-first workup and next-best-step decisions. Emphasizes classic vignette buzzwords (Charcot/Reynolds, Courvoisier, double-duct sign) and when to choose HIDA, ERCP, or surgery.
A Step 2 CK–focused surgical breast lesson covering triple assessment and age-based workup, benign lesions, breast cancer types, and next-best-step management from palpable mass and nipple discharge through inflammatory breast cancer, receptors, and axillary staging.
A board-focused walk through the three phases of wound healing (key cells, collagen shift, cofactors) and surgical site infections — organism-by-timing, wound classification, prophylaxis, and the next-best-step decisions for early wound infection, dehiscence, and necrotizing fasciitis.
A board-focused walkthrough of surgical fluid management — resuscitation vs maintenance, IV fluid selection, and the 4-2-1 rule — plus the classic post-op electrolyte disturbances (hyponatremia, NG-suction alkalosis, hypocalcemia, hyperkalemia, refeeding) and the enteral-vs-parenteral nutrition decision, each framed as a next-best-step.
A Step 2 CK-focused lesson on the three colonic surgical emergencies — perforation, volvulus, and ischemic colitis — built around board buzzwords and next-best-step decisions (who gets decompressed, who gets antibiotics, and who goes to the OR).
A board-focused walkthrough of abdominal wall hernias: the anatomy that separates indirect, direct, and femoral groin hernias, the exam landmarks that localize them, and the reducible → incarcerated → strangulated triage that drives every next-best-step decision.
A boards-focused triage of the acute red eye: separate the benign causes (viral/allergic conjunctivitis, subconjunctival hemorrhage) from the sight-threatening emergencies (angle-closure glaucoma, bacterial/HSV keratitis, anterior uveitis, scleritis, endophthalmitis) using vision, pain, pupil, injection pattern, and fluorescein — with the exact "next best step" the exam rewards.
A STEP 2 CK-focused lesson on acute vs chronic vision loss, organized by tempo and pain, covering the classic buzzwords, fundus findings, and next-best-step management for CRAO, CRVO, retinal detachment, vitreous hemorrhage, amaurosis fugax/GCA, acute angle-closure glaucoma, optic neuritis, and the chronic causes (open-angle glaucoma, cataract, AMD, diabetic retinopathy).
A boards-focused glaucoma lesson contrasting chronic primary open-angle disease (painless peripheral loss, cupping, latanoprost first-line) with acute angle-closure glaucoma (a painful red-eye emergency treated by rapid IOP lowering and definitive laser peripheral iridotomy), including next-best-step vignettes, a comparison table, and drug-mechanism mnemonics.
A Step 2 CK high-yield lesson separating cataracts (cloudy media needing surgery) from refractive errors (clear media corrected by lenses), built around board discriminators — red reflex, pinhole test, "second sight," and leukocoria — with next-best-step decisions and comparison tables.
A board-focused ophthalmology lesson contrasting diabetic and hypertensive retinopathy by findings, stage, and next-best-step management, anchored on classic vignette buzzwords. Covers NPDR/PDR, DME, VEGF-driven neovascularization, the Keith-Wagener-Barker grades, malignant hypertension with correct graded BP-lowering targets, and the ETDRS 4-2-1 rule.
A high-yield Step 2 CK approach to sudden painless monocular vision loss, contrasting retinal detachment, CRAO, and CRVO by buzzwords, fundoscopy, and the next-best-step — including GCA workup and stroke-pathway management for CRAO.
A Step 2 CK walkthrough of uveitis and scleritis: recognizing each painful red eye, tying it to its systemic disease (HLA-B27, sarcoid, RA, GPA), using the phenylephrine test to separate scleritis from episcleritis, and choosing the correct next-best-step management.
A Step 2 CK-focused lesson on distinguishing preseptal (anterior to the orbital septum, benign) from orbital (postseptal, vision- and life-threatening) cellulitis, driving the next-best-step decisions around CT imaging, IV antibiotics with MRSA coverage, and recognizing cavernous sinus thrombosis.
A high-yield, boards-focused neuro-ophthalmology lesson covering pupillary abnormalities (RAPD, Horner, Adie, Argyll Robertson), CN III/IV/VI palsies, and papilledema/IIH, organized around localization, buzzwords, and next-best-step decisions. Emphasizes the exam-critical fork of pupil-involving (aneurysm) vs pupil-sparing (microvascular) CN III palsy — noting that pain does not distinguish them — and the image-before-LP rule for raised ICP.
A high-yield board review of the three exam-favorite pediatric eye diseases — strabismus/amblyopia, retinoblastoma, and retinopathy of prematurity — anchored on the two red-flag signs (leukocoria and strabismus) with vignette buzzwords and next-best-step decisions.
Age-related macular degeneration causes painless, progressive loss of central vision in older adults; the boards test distinguishing gradual dry AMD (drusen, managed with AREDS2 vitamins and smoking cessation) from acute wet AMD (choroidal neovascularization with metamorphopsia, treated urgently with intravitreal anti-VEGF).
A high-yield Step 2 CK review of ocular trauma and chemical burns organized around next-best-step triage: irrigate chemical burns immediately, shield a suspected open globe, and recognize hyphema, orbital blowout fracture, and retrobulbar hemorrhage by their buzzwords and management.
A STEP 2 CK-focused walkthrough of acute otitis media, otitis media with effusion, and acute (including necrotizing) otitis externa — anchored on otoscopic diagnosis, the observe-vs-treat antibiotic algorithm, and the "next best step" for complications like mastoiditis and skull-base osteomyelitis.
A board-focused walkthrough of hearing loss and tinnitus that splits every case into conductive vs sensorineural, drills the Weber/Rinne pattern and classic etiology buzzwords, and pins down the next-best-step for the emergencies — sudden SNHL and unilateral/asymmetric loss suggesting vestibular schwannoma.
A Step 2 CK high-yield lesson on vertigo that anchors on the peripheral-vs-central distinction, then walks through BPPV, vestibular neuritis/labyrinthitis, Ménière disease, and posterior-circulation stroke via buzzword vignettes and next-best-step decisions. Includes a comparison table plus the INFARCT (HINTS) and COWS mnemonics.
A Step 2 CK–focused ENT lesson on sinusitis and rhinitis, built around the board decisions: viral vs. acute bacterial rhinosinusitis criteria, first-line antibiotics, can't-miss complications (mucormycosis, orbital involvement), and rhinitis management with intranasal corticosteroids first-line.
A Step 2 CK high-yield lesson on pharyngitis and tonsillitis centered on identifying Group A Strep with the Centor/McIsaac score and RADT, first-line penicillin/amoxicillin, and the classic board vignettes (peritonsillar abscess, EBV mono with the amoxicillin rash) plus suppurative and non-suppurative complications.
A board-focused walkthrough of epistaxis: anterior (Kiesselbach's plexus/Little's area) versus posterior (sphenopalatine artery) bleeds, the stepwise next-best-step management ladder, and classic vignettes including the anticoagulated elder and the adolescent male with JNA.
A board-focused walkthrough of head and neck squamous cell carcinoma: the tobacco/alcohol, HPV, and EBV etiologic pathways with classic vignette buzzwords. It drills the next-best-step decisions (FNA for an adult neck mass, laryngoscopy for persistent hoarseness, nasopharyngoscopy for a nasopharyngeal mass) and stage-based single- vs multi-modality management the boards test.
A high-yield ENT lesson on salivary gland disorders spanning obstruction, infection, autoimmune disease, and neoplasia, framed around board buzzwords and next-best-step decisions. Emphasizes submandibular stones, S. aureus parotitis, mumps, the benign-vs-malignant tumor spread, FNA-first workup, and Sjögren-associated MALT lymphoma.
A board-focused approach to neck masses: triage by age, location, and duration, then apply next-best-step logic — FNA (never excisional biopsy first) for the adult lateral mass, Sistrunk for the midline thyroglossal duct cyst, carotid body tumor you never biopsy, and "metastatic SCC until proven otherwise" in the older smoker.
A high-yield Step 2 CK walkthrough of hoarseness: when to scope (≥2–3 weeks or red flags), the benign vocal-fold lesions, vocal-cord paralysis with RLN anatomy, and laryngeal SCC — built around next-best-step decisions and classic vignette buzzwords.
A Step 2 CK high-yield lesson on ENT airway emergencies, framed around buzzword recognition and next-best-step decisions across croup, epiglottitis, bacterial tracheitis, deep neck space infections (peritonsillar, retropharyngeal, Ludwig angina), and angioedema. Emphasizes the core rule: secure an unstable airway before imaging or workup.
A boards-focused lesson on Bell palsy: acute idiopathic peripheral (LMN) CN VII paralysis, keyed to the forehead-sparing UMN-vs-LMN distinction, classic vignette buzzwords, and the next-best-step management chain (clinical dx → early steroids + eye protection, antivirals reserved for Ramsay Hunt/severe cases).
A boards-focused map of the four developmental streams (gross motor, fine motor, language, social/cognitive) from birth to 5 years, anchored to median ages and the upper-limit red flags. Emphasizes the classic delay vignettes and their NEXT BEST STEP — hearing test first for isolated language delay, serum CK for the boy with Gower sign and calf pseudohypertrophy, and chromosomal microarray plus Fragile X with immediate Early Intervention for global developmental delay.
A Step 2 CK–focused walkthrough of neonatal jaundice that separates benign physiologic and feeding-related unconjugated patterns from dangerous hemolytic and conjugated (biliary atresia) causes, anchoring on the two boards forks — bilirubin fraction and timing — and the exact next-best-step in both workup and management.
High-yield STEP 2 CK lesson on the APGAR score and neonatal resuscitation (NRP): the five scored components and cutoffs, the golden-minute algorithm, and next-best-step decisions—PPV at HR <100 or apnea, chest compressions + 100% O₂ at HR <60, and epinephrine for persistent HR <60. Corrected: removed the unsourced Joseph Butterfield backronym-origin claim (replaced with an accurate eponym/backronym note), tightened golden-minute airway wording away from routine suctioning, and specified 'effective PPV (chest moving)' before compressions.
A high-yield Step 2 CK comparison of the three classic pediatric airway infections — bronchiolitis, croup, and epiglottitis — organized by age, buzzwords, imaging signs, and next-best-step management. Emphasizes the board traps: supportive-only care for bronchiolitis and the do-not-examine-the-throat airway emergency of epiglottitis.
A board-focused walkthrough of the three classic pediatric surgical GI conditions — pyloric stenosis, intussusception, and Hirschsprung disease — organized by buzzword vignette, best diagnostic test, and the tested next-best-step in management. Emphasizes the high-yield trap of operating before resuscitation or enema reduction.
A board-focused tour of the classic childhood exanthems — measles, scarlet fever, rubella, fifth disease, and roseola, plus varicella, hand-foot-mouth, and the must-not-miss Kawasaki mimic — organized by pathognomonic buzzword, feared complication, and next best step.
A Step 2 CK-focused walkthrough of the childhood immunization schedule, emphasizing which vaccines are due at each well-child visit, the live-versus-inactivated rules, and the true contraindications versus the classic 'false' reasons students wrongly defer vaccination.
A high-yield Step 2 CK walkthrough of normal growth parameters, the failure-to-thrive workup (weight falls first; history and observed feeding before labs), normal-variant short stature, and the classic pediatric nutritional deficiencies including marasmus vs. kwashiorkor.
A board-focused tour of the classic genetic and chromosomal syndromes — autosomal trisomies, sex-chromosome aneuploidies, microdeletions, imprinting disorders, and Fragile X — organized around buzzword recognition, the associated cardiac lesion, and the confirmatory next-best test.
A boards-focused walkthrough of the three classic neonatal emergencies—RDS, NEC, and sepsis—using timing, feeding status, and the signature radiograph to drive diagnosis and the correct next-best step. Built around vignette buzzwords and management decisions tested on Step 1 and Step 2 CK.
A board-focused walkthrough of non-accidental trauma: red flags and high-specificity injuries (classic metaphyseal/posterior-rib fractures, abusive head trauma, immersion burns), the validated TEN-4-FACESp bruising rule, mimics to exclude, and the mandatory next step — report to CPS on reasonable suspicion. Emphasizes NEXT-BEST-STEP decisions the way Step 2 CK tests them.
A STEP 2 CK-focused walkthrough of pediatric dehydration: estimating the deficit, grading severity, choosing oral versus IV rehydration, and managing iso-, hypo-, and hypernatremic states with the correct fluid math and next-best-step decisions.
A high-yield USMLE lesson on pediatric congenital heart disease built around the acyanotic-vs-cyanotic framework, classic buzzwords, syndrome associations, and next-best-step decisions (hyperoxia test, PGE1, echo). Includes the 5 T's and PROVe mnemonics, TGA and tet-spell vignettes, and comparison tables.
A boards-focused review of the ethical-legal framework for patient decision-making: the primacy of autonomy, how to assess decision-making capacity (and how it differs from legal competence), the elements and exceptions of informed consent, the advance-directive/surrogate hierarchy, and exactly when confidentiality must be broken.
A board-focused walkthrough of end-of-life ethics built around the core rule that a patient with capacity always decides, with advance directives, surrogate standards, comfort-care principles, and next-best-step vignettes. Covers hospice vs palliative care and brain death vs PVS vs coma.
A board-focused ethics lesson on decision-making capacity (clinical, decision-specific, four Appelbaum criteria) versus legal competence, the default surrogate hierarchy, advance directives (living will vs. healthcare proxy), and the substituted-judgment/best-interest standards that drive next-best-step decisions.
A high-yield Step 2 CK ethics lesson on consent in minors: the default of parental permission plus child assent, and the exam-critical exceptions — emergencies, emancipated and mature minors, and confidential care for STIs, contraception, pregnancy, and substance use — with next-best-step logic for maintaining confidentiality and overriding parental refusal of life-saving care.
A Step 2 CK high-yield lesson on medical confidentiality and its legally and ethically mandated exceptions — reportable diseases, Tarasoff duty to warn, abuse reporting, HIV partner notification, and adolescent confidentiality — framed around next-best-step decisions.
A high-yield Step 2 CK ethics lesson on reproductive ethics, built around the two questions the boards actually test — who is the decision-maker and whether their competent choice is respected — covering minor consent frameworks, adolescent confidentiality and its abuse-reporting exception, maternal-fetal conflict, and physician duties. Includes three classic next-best-step vignettes, a consent-framework comparison table, and the emancipated-minor mnemonic.
How the USMLE tests research ethics: IRB approval before any human-subjects study begins, the Belmont Report's three principles, informed consent and equipoise, and the next-best-step calls on placebo use, vulnerable populations, and conflicts of interest.
Justice in medicine means allocating scarce resources by medical need and likelihood of benefit — never ability to pay or social worth — through transparent protocols, with disaster triage ("greatest good for the greatest number") and EMTALA as the highest-yield board scenarios.
How the boards test conflicts of interest and professionalism: recognize when a secondary interest — gifts, referrals, industry ties, relationships, or a colleague's impairment — threatens patient welfare, then pick the next best step, which is usually to disclose, decline, recuse, or report. Fee-splitting/kickbacks (Anti-Kickback Statute) are always illegal; self-referral is restricted by the Stark Law and requires disclosure.
How the boards test impaired, incompetent, and unethical colleagues: your overriding duty is to protect patients — prevent imminent harm immediately, then report through the proper chain (supervisor → Physician Health Program → state licensing board), never ignoring or covering for a colleague. A good-faith reasonable concern is enough to report; you do not need proof.
A Step 2 CK ethics lesson on determination of death (UDDA, brain-death criteria and apnea testing) and organ-donation ethics (dead donor rule, OPO-driven consent, DBD vs DCD), built around board-style next-best-step decisions.
A board-focused lesson on truth-telling and breaking bad news: veracity and patient autonomy as the defaults, the SPIKES protocol for delivery, and the correct next steps when families request nondisclosure, patients waive information, or a medical error must be disclosed.
A board-focused walkthrough of the core epidemiology triad: matching each study design to its correct measure of association (OR, RR, prevalence), recognizing the classic biases, and distinguishing confounding from effect modification.
A Step 1 high-yield lesson on randomized controlled trials covering randomization, allocation concealment, blinding levels, the evidence hierarchy, trial phases, and analysis methods, with classic vignettes on intention-to-treat and crossover designs.
A board-focused breakdown of the two core observational designs — cohort (group by exposure → follow forward → relative risk) versus case-control (group by disease → look backward → odds ratio) — with 2×2 setup, worked OR/RR computations, and the biases Step 1 loves to test.
A board-focused breakdown of confounding versus effect modification, built around the stratified-analysis test used to distinguish them, with classic vignettes (coffee–cancer confounded by smoking; OCP–MI modified by smoking) and explicit next-best-step decisions.
A Step 1 high-yield lesson distinguishing validity (accuracy; freedom from systematic error/bias) from reliability (precision; freedom from random error), anchored by the dartboard model and next-best-step vignettes on instrument calibration and inter-rater agreement.
Bradford Hill's nine criteria are viewpoints — not a checklist — for judging whether an exposure–outcome association is causal. Board essentials: temporality is the only required criterion, dose–response and strength argue strongly for causation, and specificity is weakest — and chance, bias, confounding, and reverse causation must always be excluded first.
A board-focused walkthrough of the drug-development pipeline: preclinical testing plus the four clinical trial phases, emphasizing the subject population, sample size, and core question that distinguishes each phase on Step 1 vignettes.
How the boards test systematic reviews and meta-analysis: reading a forest plot (does the CI/diamond cross the line of no effect?), interpreting I² heterogeneity and fixed-effect vs random-effects models, and recognizing funnel-plot asymmetry as publication bias.
A boards-focused EBM lesson covering the exam's four core tasks — choosing study designs/statistical tests, interpreting sensitivity/specificity/PPV, computing RR/OR/ARR/NNT, and identifying bias — anchored in the 2×2 table with next-best-step reasoning.
A high-yield boards lesson on qualitative and survey research methods, contrasting qualitative (hypothesis-generating, thematic, purposive sampling) with survey approaches and drilling the board-favorite concepts of reliability vs. validity (precision vs. accuracy; random vs. systematic error) and the common self-report biases with next-best-step fixes.
A Step 1 biostatistics lesson on intention-to-treat analysis (analyze as randomized, preserves randomization, conservative/toward-null in superiority trials, anti-conservative in non-inferiority) contrasted with per-protocol and as-treated, paired with sensitivity analysis as the tool that stress-tests ITT results against missing-data and other assumptions.
A board-focused tour of research bias for STEP 1: how to name each bias from a vignette, which study design is most vulnerable, and the design or analytic fix — including the confounding vs effect-modification discriminator and the lead-time vs length-time screening traps.
A boards-focused walkthrough of the four shock categories — hypovolemic, cardiogenic, obstructive, and distributive — anchored to their signature preload, cardiac output, SVR, and SvO2 profiles, with the classic vignette buzzwords and the correct immediate next step for each.
A board-focused walkthrough of reading the CBC — using MCV, RDW, and the reticulocyte count to classify anemia, and reading the WBC differential and platelet count — to land the diagnosis and the next best step.
A Step 2 CK–focused walkthrough of the basic metabolic panel: a fixed six-step reading habit, the core formulas (anion gap, Winter's, corrected Na⁺, BUN:Cr/FENa), and the classic sodium, potassium, anion-gap acidosis, and acute-kidney-injury patterns with their next-best-step decisions.
A stepwise approach to abnormal liver chemistries for Step 2 CK: assign the pattern — hepatocellular vs cholestatic (R factor) vs isolated hyperbilirubinemia (enzymes normal) — then use enzyme magnitude, the AST:ALT ratio, and bilirubin fractionation to reach the diagnosis and next best step.
A board-style, systematic 5-step framework for arterial blood gas interpretation — primary disorder, compensation formulas, anion gap, and delta gap — anchored to classic mixed-disorder vignettes and next-best-step management.
A board-focused walkthrough of systematic ECG interpretation for Step 2 CK: normal intervals and rate/axis shortcuts, STEMI localization by lead and culprit artery, AV block differentiation with next-best-step management, and the classic buzzword patterns (WPW, pericarditis, Wellens, hyperkalemia).
A board-focused, systematic walkthrough of chest X-ray interpretation for Step 2 CK: the RIPE quality check and ABCDE read, classic buzzword findings mapped to diagnoses, and vignette-driven next-best-step decisions for CHF, tension pneumothorax, and perforated viscus.
A Step 2 CK-focused walkthrough of urinalysis that pairs each dipstick and microscopy finding with its diagnosis and next best step, anchored on cast recognition and the nephritic/nephrotic/tubulointerstitial framework.
A board-focused guide to reading PT/INR and aPTT: localize the defect by pattern, use the mixing study to split factor deficiency from inhibitor, and apply next-best-step logic for hemophilia, lupus anticoagulant, DIC, and warfarin reversal.
A Step 2 CK rapid-recognition lesson on classic eponymous physical exam signs, mapping each buzzword to its diagnosis and next-best-step, with emphasis on high-yield confusable pairs (pulsus paradoxus vs Kussmaul, Osler vs Janeway, cholecystitis vs cholangitis) and same-name traps.
A next-best-step approach to the electrolyte and acid-base abnormalities Step 2 CK loves — hyponatremia (osmolality → volume status), hyperkalemia (ECG → calcium first), high anion-gap acidosis (MUDPILES), and hypercalcemia (PTH-driven) — pairing each decisive confirmatory lab with the first correct action.
A board-focused framework for the febrile patient: distinguish fever from hyperthermia, triage the can't-miss emergencies (febrile neutropenia, meningitis, sepsis, endocarditis, drug-induced hyperthermia), then work up prolonged fever as FUO — all anchored to the reflex that fever plus neutropenia demands empiric antibiotics within one hour.
A systems-based tour of patient safety: James Reason's Swiss Cheese Model, active vs. latent failures, and the slip–lapse–mistake–violation taxonomy, all anchored to the \"next best step\" the boards test (near miss → non-punitive report, sentinel event → RCA, proactive → FMEA) plus the event-severity ladder, the effectiveness hierarchy, Just Culture, and error disclosure.
Quality improvement is the prospective, systems-based discipline (PDSA to test changes, FMEA to anticipate failures), while root cause analysis is the retrospective, blame-free investigation triggered by a sentinel event. Boards test which tool to reach for and reliably reward the answer that redesigns the system over one that relies on vigilance or re-education.
Handoffs are high-risk care transitions where communication failures drive sentinel events; SBAR structures urgent clinical messages while I-PASS structures shift sign-out. Closed-loop read-back plus the two-challenge/CUS escalation tools are the board-favored, systems-level fixes over individual blame.
A board-focused walkthrough of medication reconciliation and the systems that prevent medication error: the four-step reconciliation workflow (BPMH → compare → reconcile → communicate), error taxonomy and definitions (error/near-miss/ADE/ADR), high-alert drugs and Tall Man lettering, the Joint Commission \"Do Not Use\" abbreviations, CPOE vs BCMA, and the just-culture/RCA-vs-FMEA framework — all delivered as the next-best-step and \"what would have prevented this\" decisions the exams test.
How the boards test informed consent (the 4 components of capacity, the elements of valid consent, exceptions, minors, and surrogate decision-making) and medical-error disclosure (prompt, honest, systems-based), all framed as next-best-step decisions anchored in patient autonomy.
A boards-focused lesson separating CMS Hospital-Acquired Conditions (the payment/present-on-admission rule) from NQF Never Events and Joint Commission sentinel events, with the tested next steps — honest disclosure, incident reporting, and root cause analysis — plus CLABSI/CAUTI prevention and the error taxonomy.
A board-focused walkthrough of how healthcare quality is measured (Donabedian structure/process/outcome, plus the Model for Improvement's balancing measures and the STEEEP aims) and improved (the Model for Improvement and rapid PDSA cycles), drilling the process-vs-outcome and RCA-vs-FMEA distinctions the exam loves to test as next-best-step decisions.
A boards-focused lesson on Just Culture — balancing system and individual accountability — and error-reporting systems, teaching how to classify human vs at-risk vs reckless behavior (Console/Coach/Punish), disclose harmful errors, and distinguish retrospective RCA from prospective FMEA. Emphasizes classic next-best-step decisions for STEP 2 CK and STEP 3.
How the boards test diagnostic error: name the cognitive bias from the vignette buzzwords, then choose the debiasing next step — broaden the differential, order the test that excludes the can't-miss diagnosis, or call a diagnostic time-out. Includes classic bias comparisons, two next-best-step vignettes (PE mislabeled as anxiety → CTPA; subdural mislabeled as intoxication → non-contrast head CT), and the post-error disclosure/RCA vs FMEA framework under a just culture.
A board-focused walkthrough of systems-based practice and care transitions: how to classify errors (active vs latent, near-miss, sentinel, never event), match the analysis tool (RCA retrospectively vs FMEA prospectively vs PDSA), and pick the safest next step at handoffs — medication reconciliation, structured I-PASS/SBAR sign-out, forcing functions, and honest error disclosure.
A board-focused review of high-reliability organizations—their five principles (Weick & Sutcliffe) and just-culture foundation—and the checklists and bundles (WHO Surgical Safety Checklist, central-line/CLABSI bundle, Universal Protocol Time Out) that prevent never events, plus how to analyze error using RCA vs FMEA and where standardization versus forcing functions sit in the safety hierarchy.
A board-focused lesson on infection prevention and hand hygiene, covering ABHR vs soap-and-water rules, the WHO 5 Moments, transmission-based precautions, device-associated HAI bundles, and the QI/systems framing tested on Step 2 CK and Step 3.
A Step 2 CK–focused management lesson on sepsis and septic shock built around the Surviving Sepsis Campaign Hour-1 bundle: cultures before antibiotics, broad-spectrum antibiotics within an hour, 30 mL/kg crystalloid, and norepinephrine-first vasopressor escalation (vasopressin second, epinephrine third) to MAP ≥65, with source control, hydrocortisone for vasopressor-dependent refractory shock, and the classic distractors emphasized.
A Step 2 CK management lesson on diabetic ketoacidosis built around the ordered algorithm — fluids first, potassium before insulin, insulin drip continued with dextrose until the anion gap closes — with two \"next best step\" vignettes and the classic pitfalls (hypokalemia, stopping insulin too early, cerebral edema, euglycemic DKA).
A management-focused Step 2 CK review of anticoagulation: choosing the agent by indication (DOAC vs warfarin vs heparin), reversing life-threatening bleeds, managing suspected HIT, and deciding when peri-procedural and initiation bridging are — and are not — needed.
A Step 2 CK management lesson on fluid and electrolyte emergencies, framed around volume status, symptom severity, and safe correction rate — covering the hyperkalemia stabilize-shift-eliminate algorithm, hyponatremia treatment by volume status with hypertonic-saline rescue, and the correction-rate pitfalls (osmotic demyelination, cerebral edema) that drive the "next best step" answer.
A Step 2 CK-focused walkthrough of acute GI bleeding management: resuscitate before you investigate, risk-stratify, give the right pre-endoscopy pharmacology (IV PPI for ulcers; octreotide + ceftriaxone for varices), transfuse restrictively, and know exactly when to escalate to endoscopy, IR, or surgery.
A Step 2 CK management lesson on perioperative risk assessment for non-cardiac surgery: the ACC/AHA stepwise algorithm, RCRI scoring, the ≥4-MET functional-capacity rule that stops most workups, and evidence-based perioperative medication management (beta-blockers, DAPT/stent timing, anticoagulation bridging, SGLT2/metformin, steroids). Emphasis throughout is the \"next best step\" — optimize and proceed, and test only when it changes management.
A Step 2 CK–focused, algorithm-first guide to managing acute asthma and COPD exacerbations — first-line therapy, ordered escalation, and the oxygen, antibiotic, and ventilation decisions that distinguish the two. Emphasizes the "next best step in management" and impending-respiratory-failure red flags.
A management-focused Step 2 CK lesson separating hypertensive emergency (severe BP plus acute target-organ damage → ICU, IV titratable agents, controlled reduction of SBP by ≤25% in the first hour) from urgency (no organ damage → oral meds, gradual outpatient lowering over 24–72 h), with condition-specific first-line agents, organ-specific BP targets, and the classic \"next best step\" pitfalls.
A high-yield, management-focused lesson on anaphylaxis emphasizing prompt IM epinephrine as the only first-line, mortality-reducing therapy, with an ordered treatment algorithm, first-line-vs-adjunct comparison, trustworthy dosing, escalation (IV epinephrine infusion; glucagon for beta-blocked patients), and the classic exam pitfalls. Built around "next best step in management" for STEP 1 and STEP 2 CK.
A Step 2 CK management lesson on blood products and transfusion: restrictive component thresholds and dosing effects, rapid recognition and next-best-step management of transfusion reactions (with the recurring rule to STOP the transfusion), the TACO-vs-TRALI distinction, and anticoagulation reversal.
A management-focused Step 2 CK lesson on acute hyperkalemia: the ECG-driven emergency approach and the stabilize–shift–remove algorithm, with confident doses, a decision table, two \"next best step\" vignettes, a mnemonic, and high-yield pitfalls.
A Step 2 CK–focused walkthrough of acute pain management: multimodal, opioid-sparing analgesia; the stepwise WHO-adapted algorithm (matched to severity and stepped down for acute pain); safe opioid selection including renal failure; and recognizing/reversing opioid toxicity — anchored on the next best step in management.